Next Article in Journal
Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression—A Preliminary Study
Next Article in Special Issue
Population Response of Rhizosphere Microbiota of Garden Pea Genotypes to Inoculation with Arbuscular Mycorrhizal Fungi
Previous Article in Journal
Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells
Previous Article in Special Issue
Grapevine Leafroll-Associated Virus 3 in Single and Mixed Infections Triggers Changes in the Oxidative Balance of Four Grapevine Varieties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The γ-Core Motif Peptides of Plant AMPs as Novel Antimicrobials for Medicine and Agriculture

by
Marina P. Slezina
,
Ekaterina A. Istomina
,
Tatyana V. Korostyleva
and
Tatyana I. Odintsova
*
Vavilov Institute of General Genetics RAS, 119333 Moscow, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(1), 483; https://doi.org/10.3390/ijms24010483
Submission received: 26 October 2022 / Revised: 11 December 2022 / Accepted: 21 December 2022 / Published: 28 December 2022
(This article belongs to the Special Issue Plant Response to Insects and Microbes)

Abstract

:
The γ-core motif is a structural element shared by most host antimicrobial peptides (AMPs), which is supposed to contribute to their antimicrobial properties. In this review, we summarized the available data on the γ-core peptides of plant AMPs. We describe γ-core peptides that have been shown to exhibit inhibitory activity against plant and human bacterial and fungal pathogens that make them attractive scaffolds for the development of novel anti-infective agents. Their advantages include origin from natural AMP sequences, broad-spectrum and potent inhibitory activity, and cost-effective production. In addition, some γ-core peptides combine antimicrobial and immunomodulatory functions, thus broadening the spectrum of practical applications. Some act synergistically with antimycotics and fungicides, so combinations of peptides with conventionally used antifungal agents can be suggested as an effective strategy to reduce the doses of potentially harmful chemicals. The presented information will pave the way for the design of novel antimicrobials on the basis of γ-core motif peptides, which can find application in medicine and the protection of crops from diseases.

1. Introduction

Antimicrobial peptides (AMPs) play a crucial role in diverse biological processes. They are universal participants of the defense system of all living beings forming the basis of innate immunity [1]. They also preserve the composition and abundance of the beneficial microbiome [2]. The occurrence of AMPs in evolutionarily distant groups of organisms demonstrates their importance as effectors of immunity mechanisms and modulators of host-microbe interactions. AMPs are structurally and functionally diverse both within and across species. Each genome harbors genes encoding from five to ten peptide families [3]. Every species contains a unique, specific pool of AMPs tuned to protect the organism against microbes and to establish interactions with beneficial microorganisms [1]. Plants usually possess more AMPs than other organisms [4]. Some peptide families, such as defensins, are evolutionary conserved, while others are restricted to particular clades (e.g., thionins in plants).
In an era of rapidly developing microbial resistance to antibiotics, the search for new alternatives is of particular importance. Extremely varied in structure and created by nature itself, AMPs represent ideal scaffolds for the development of novel anti-infective agents. The main advantages of AMPs include their ability to act rapidly, affect a variety of pathogens and escape rapid resistance development [5]. Plant AMPs are synthesized on ribosomes. They usually consist of 20−50 amino acid residues, have a net positive charge, and are amphipathic, mostly hydrophilic, enriched in cysteine, glycine, and positively charged residues [6]. Based on the similarity in 3D structure and cysteine signature, plant AMPs are classified into several families, such as defensins, thionins, non-specific lipid transfer proteins (nsLTPs), α-hairpinins, hevein- and knottin-like peptides [7]. Despite obvious advantages, the practical use of natural AMPs is hampered by such drawbacks as limited quantities of peptides that can be isolated from natural sources, costly peptide synthesis, problems with appropriate folding, sensitivity to protease degradation, low activity at physiological salt concentrations, toxicity to human cells, etc. In this context, the main focus of research is on the development of synthetic analogues based on natural AMP sequences, devoid of limitations of natural AMPs. The design of AMP analogues includes truncation of sequences, mutation of specific amino acid residues, enrichment of the original sequence with certain types of residues, incorporation of unnatural amino acid residues, etc. [4].
Truncation of AMP sequences can provide highly active and simultaneously low-cost antimicrobials. This approach assumes knowledge of the sites of the AMP molecule associated with antimicrobial activity. Analysis of cysteine-rich peptides (CRPs) displaying antimicrobial activity showed that they all share a common structural element, the so-called γ-core, which is a conserved sequence pattern existing in three isoforms named dextromeric or D-isoform (NH2…[X1–3]-[GXC]-[X3–9]-[C]…COOH), levomeric 1 or L1-isoform (NH2…[C]-[X3–9]-[CXG]-[X1–3]…COOH) and levomeric 2 or L2-isoform (NH2…[C]-[X3–9]-[GXC]-[X1–3]…COOH) [8]. The γ-core adopts anti-parallel β-hairpin conformation with a central location in many antimicrobial peptides. It is positively charged and amphiphilic, which facilitates interactions with the membranes [8]. This motif was discovered in host defense peptides from phylogenetically distant organisms, suggesting that it plays an ancient and essential role in effector molecules governing host-pathogen interactions.
Since the discovery of the γ-core, a significant number of papers have appeared analyzing the role of this motif in the antimicrobial activity of AMPs and identifying amino acid residues essential for activity. The fact that γ-core determines the antimicrobial properties of the AMP was established by the studies in which the γ-core of one defensin was replaced by the γ-core of another, which was accompanied by a change in antimicrobial properties [9,10]. In subsequent studies, short peptides corresponding to the γ-core motifs were synthesized to assay their antimicrobial activity. Further “mutating” particular residues in these peptides enables the identification of the residues crucial for activity and even improves antimicrobial potency. Besides shedding light on the problem of structure-function relationship in plant AMPs, the γ-core-based short peptides can find applications in medicine and agriculture as new antimicrobial agents.
In this review, we summarized the available data on the γ-core peptides of plant AMPs. The material is grouped by botanical families of plants that served as a source of AMPs for the synthesis of γ-core peptides. We believe that the presented information will facilitate further studies of the antimicrobial determinants in CRPs and pave the way for the construction of novel short peptide antimicrobials on the basis of natural AMP sequences.

2. γ-Core Motifs of Defensins

Plant defensins belong to a highly conserved AMP family found in all multicellular organisms. They display a variety of functions, including antifungal, antibacterial, inhibition of proteases and amylases, inhibition of protein synthesis in cell-free systems, blockage of ion channels, heavy metal tolerance, and a role in sexual reproduction [11,12]. The molecular mechanisms underlying the biological activity of plant defensins are just beginning to become clear: they include interactions with specific membrane lipids of the pathogens, production of reactive oxygen species (ROS), and induction of cell wall stress. Despite sequence dissimilarity, plant defensins share a common 3D structure, which involves a triple-stranded antiparallel β-structure and an α-helix going in parallel to the β-sheet [13,14,15,16]. The γ-core represents a portion of the molecule encompassing the β2 and β3 strands and their connecting loop (Figure 1). Furthermore, a similar signature named α-core is located in the N-terminal half of the peptides, although it is not positively charged and does not adopt a β-hairpin conformation as the γ-core. Of plant AMPs, defensins were predominantly used in the γ-core structure/function studies.

2.1. Radish Defensins Rs-AFP1 and Rs-AFP2 (Brassicaceae)

Radish seed defensins Rs-AFP1 и Rs-AFP2 were among the first defensins isolated from plants [17], for which the problem of structure-function relationships was inferred. They inhibit the growth of filamentous fungi such as Alternaria brassicola, Botrytis cinerea, and Fusarium culmorum at micromolar concentrations, causing hyper branching of hyphae. The IC50 (concentration necessary for 50% inhibition of the pathogen growth) values for these fungi are as low as 2 µg/mL for Rs-AFP2 and vary from 5 to 15 µg/mL for Rs-AFP1 [17]. Radish defensins are active not only against plant pathogenic fungi but against human pathogens, including Candida albicans. Studies of the mode of action of Rs-AFP2 on C. albicans showed that the peptide interacted with the fungal glucosylceramides and induced apoptosis in the yeast cells. Further studies demonstrated that the defensin caused cell wall stress, mislocalization of septins, and accumulation of ceramides in C. albicans [18]. Moreover, both radish defensins prevented biofilm formation in C. albicans and acted synergistically with the antimycotics caspofungin and amphotericin B. Rs-AFP2 was more potent than Rs-AFP1 against planktonic and biofilm cultures [19]. Sequence analysis shows that the radish defensins possess the γ-core motif GSCNYVFPAHKC and the α-core motif GVCGNNNAC (Table 1, Figure S1).
The role of the γ- and α-core motifs in the antimicrobial activity of the radish defensins was explored in a number of studies. A series of 15-mer overlapping peptides covering the Rs-AFP2 sequence was produced by De Samblanx et al. (Table 1, Figure S1) [21]. Each peptide overlapped by 11 residues with the consecutive peptide. Peptide 4 covered the α-core motif, while peptide 9 encompassed the γ-core motif of Rs-AFP2. Antifungal activity assays against five plant pathogens (F. culmorum, A. brassicola, Ascochyta pisi, B. cinerea, and Verticillium dahliae) showed that only peptides 6, 7, 8, and 9 covering the region from Cys21 to Cys47 including the γ-core region were active against the selected fungi at MIC (minimal inhibitory concentration) from 30 to 250 µg/mL. V. dahliae was the most sensitive pathogen, equally potently inhibited by peptides 6−9 at a concentration of 30 µg/mL. Peptide 9 was also the most active against F. culmorum. Peptide 8 was the most active against A. brassicola. A. pisi and B. cinerea were poorly inhibited by all peptides. Of interest, peptide 10, covering most of the γ-core motif but devoid of the GXC signature, was inactive against the tested fungi. Conversely, the discovery of antifungal activity in peptides 6−8 lacking most of the γ-core points to the importance of the residues located N-terminally to the γ-core for antimicrobial activity. No correlation was observed between the peptide’s charge and antimicrobial activity: peptides 8, 9, and 10 had the same charge of +1. However, only peptides 8 and 9 were active against the tested fungi (Table 1).
A synthetic loop-mimetic peptide with a Cys36–Cys45 bond comprising most of the γ-core motif exhibited antifungal activity (Table 1). The Y38A substitution in this cyclic peptide decreased antifungal potency. The importance of Tyr38 for antifungal activity was further confirmed in antifungal assays of Rs-AFP2 substitution lines against F. culmorum [20]. Substitutions Y38G, F40M, P41∆, and K44Q in the γ-core motif reduced the antifungal potency of Rs-AFP2 (Table 1). The substitution of residues in close proximity to the GXCX3-9C signature, such as A31W and Y48I, also decreased inhibition. Interestingly, V39R substitution in Rs-AFP2 increased the antifungal potency compared to the native defensin (Table 1). Using Accelerated Molecular Dynamics, it was shown that the mutation V39R stabilizes the defensin structure and increases membrane deformation activity compared to the native peptide [24].
Another series of synthetic 19-mer peptides encompassing the γ-core region of Rs-AFP2 were synthesized, and their antimicrobial activity was assayed (Table 1) [22]. A peptide MBG01 covered residues from 31 to 49. In MBG02, the cysteine residues were substituted with α-aminobutyric acid. In MBG03, the cysteine residues were also substituted with α-aminobutyric acid, and the terminal residues Ala31 and Phe49 were substituted with cysteine. Peptide MBG04 was the same as MBG03. Only the α-aminobutyric acids at positions 36 and 45 were replaced by D-cysteines. By oxidation in DMSO, a disulfide bond was formed between the terminal cysteine residues in MBG03 and MBG04 and between the two D-cysteines in MBG04. Testing of the antifungal activity of the γ-core peptide MBG01 and its variants against F. culmorum showed that while Rs-AFP2 IC50 was 5 μg/mL, for MBG01, it was higher—33 μg/mL. Substitution of cysteines with α-aminobutyric acid preventing disulfide bond formation restored high antifungal activity of the peptide with IC50 of 8 μg/mL. The introduction of a disulfide bond between the terminal residues decreased the antifungal potency of the γ-core peptide MBG03 two-fold (IC50 = 17 μg/mL). The introduction of a second disulfide bond in MBG04 slightly enhanced the antifungal potency of the peptide (IC50 = 15 μg/mL). Thus, the highest activity compared to the original peptide MBG01 was observed in peptide MBG02, followed by MBG04 and MBG03, indicating that multimerization via disulfide bond formation is not necessary for the activity of the Rs-AFP2 γ-core peptides. Deletion of two amino acid residues (Ala31 and Arg32) from the N-terminus of MBG01 decreased the antifungal potency of the peptide MAT09 (IC50 = 41 μg/mL). Substitution of cysteine residues in peptide MAT09 with α-aminobutyric acid producing MBG05 abolished the antifungal activity of the peptide. Short, 6-mer peptides MBG06 and MBG08 were produced from the N-terminus of MBG01. Peptide MBG08 was identical to MBG06 but carried a substitution of cysteine with α-aminobutyric acid. The activity of the short MBG06 peptide was about five times lower than that of the original peptide MBG01. The peptide MBG08 was inactive. Similarly, 6-mer peptides MBG07 and MBG09 were produced from the C-terminal region of MBG01, and peptide MBG09 carried substitutions of cysteines with α-aminobutyric acid. Interestingly, while MBG09 was inactive, MBG07 was highly active (IC50 = 16 μg/mL). Thus, the activity of short MBG01-derived peptides depended on the presence of cysteine residues which possibly cause peptide dimerization or multimerization crucial for activity. Note that the peptide MAT02 harboring the α-core sequence was inactive against F. culmorum (Table 1).
In order to locate functionally important residues in the γ-core peptide MBG01, all the overlapping 13- to 20-mer peptides from position 26 to 49 in the Rs-AFP2 amino acid sequence were synthesized (Table 1) [22]. All cysteines were replaced by α-aminobutyric acid. The 20-mer peptide 30-49 containing the γ-core had the highest activity (IC50 = 5 μg/mL) identical to that of the native peptide Rs-AFP2. Deletion of Arg32 significantly decreased antimicrobial activity (IC50 = 247 μg/mL) [22]. Deletion of His33 further decreased antimicrobial potency (IC50 ˃ 400 μg/mL). A similar reduction in activity was observed when the C-terminal YF was deleted. Furthermore, it was also shown that the sequences less than 16 residues in length were, on the whole, less active than the longer peptides.
The antimicrobial properties of the γ-core of Rs-AFP2 against plant and human pathogens were further confirmed by Sathoff et al. (Table 1) [23]. The peptide appeared active against Fusarium tricintcum (IC50 = 5.3 μM). The bacteria E. coli, Pseudomonas syringae pv. syringae and Sinorhizobium meliloti were also sensitive to the Rs-AFP2 γ-core peptide. These results are in contrast with those of De Samblanx et al. [20], who showed the insensitivity of the γ-core-containing peptides of Rs-AFP2 to the bacterial pathogens in the concentration range from 3 to 400 μg/mL.
Thus, the antimicrobial properties of the γ-core-containing peptides of the radish defensins were shown in a number of studies. However, the accumulated data indicate that the antifungal activity of these defensins is not associated only with the γ-core motif regions. Analysis of different substitution lines of the radish defensins allowed De Samblanx et al. to conclude that there is a second antifungal site composed of the residues Thr10, Ser12, Leu28, and Phe49, which form a cluster in the 3D structure of the defensin molecule [20]. The residues of this cluster are not part of the α-core region of Rs-AFP2 either. The introduction of a positively charged residue within this cluster increases the antifungal activity of the peptide. Furthermore, analysis of the antifungal activity of Rs-AFP1 vs. Rs-AFP2 showed that Rs-AFP2 was 2−30 times more efficient in inhibiting spore germination of plant filamentous fungi than Rs-AFP1 [17], while amino acid comparison demonstrated that the peptides differ only by two amino acid residues (Glu5 in Rs-AFP1 is substituted for Gln in Rs-AFP2, and Asn27 in Rs-AFP1 is replaced by Arg in Rs-AFP2) in the N-terminal half of the molecule which increases the net positive charge of Rs-AFP2, but which are beyond the α- and γ-core regions.

2.2. Brassica Hybrid Defensins BhDef1 and BhDef2 (Brassicaceae)

From another Brassicaceae species found in Thailand, Brassica hybrid cv. Pule, two defensin genes named BhDef1 and BhDef2 were isolated [25]. The defensins BhDef1 and BhDef2 showed sequence similarity to defensins of other Brassicaceae species. BhDef1 displayed the highest sequence similarity (85% identity) with the γ-thionin from Barbarea vulgaris, and BhDef2, 78% similarity with the Brassica napus defensin. The γ-core motif of BhDef1 was identical to that of the radish Rs-AFP2 except for a single substitution of Asn for Tyr, while in BhDef2, the γ-core differed from the radish γ-core by six amino acid residues (Table 2, Figure S1). The α-core motif of BhDef1 was identical to that of Rs-AFP2.
Eight peptides were designed on the basis of BhDef1 and BhDef2 sequences (Table 2) [25]. Five peptides were derived from BhDef1. BhDef11 covered the first 15 amino acid residues. BhDef12 corresponded to the α-core of the defensin. BhDef12M was the same as BhDef12. Only three successive Asn residues were substituted for Arg to increase the positive charge (+3). BhDef13 encompassed the γ-core region with additional seven residues from the N-terminus, and finally, BhDef14 spanned the N-terminal half of the defensin molecule (26 residues) and had the highest net charge of +4. Three peptides originated from BhDef2. BhDef21 corresponded to residues 9−25 of the polypeptide chain. BhDef22 encompassed the γ-core region with additional seven residues from the N-terminus. BhDef23 included the α-core and was negatively charged (−1). The antifungal activity of the peptides was assayed against Colletotrichum gloeosporoides causing anthracnose disease (fruit rot). Antibacterial activity was assayed against Staphylococcus aureus (MRSA) and Salmonella typhi. BhDef12M showed an inhibition zone of 4 mm at a concentration of 512 µg/mL against C. gloeosporoides. BhDef13, BhDef14, and the negatively charged BhDef23 were also active but at a higher concentration of 1.024 mg/mL (inhibition zones of 7, 3, and 10 mm, respectively). Six peptides (BhDef11, BhDef12M, BhDef13, BhDef14, BhDef21, and BhDef23) were active against the Gram-positive bacterium MRSA and the Gram-negative bacterium Salmonella typhi. The MIC99 values varied from 0.93 to 2.93 mg/mL. BhDef14 covering the N-terminal half of the molecule was the most active peptide against both bacterial species, possibly due to the highest net positive charge of the peptide.
In summary, in contrast to the radish defensins, both the α-core and γ-core regions of B. hybrid defensins BhDef1 and BhDef2 were active against the fungus C. gloeosporoides and human pathogenic bacteria Staphylococcus aureus and Salmonella typhi, however, at high millimolar concentrations.

2.3. MsDef1 and MtDef4 (Fabaceae)

MsDef1 is an antifungal seed defensin of a perennial plant Medicago sativa, which inhibits the growth of filamentous fungi, including F. graminearum [9]. It belongs to morphogenic defensins inducing hyperbranching. MtDef4 is an apoplast-located defensin of Medicago truncatula, which is expressed in different tissues either constitutively or in response to stress factors. MtDef4 is a more potent inhibitor of F. graminearum than MsDef1 [9]. In contrast to MsDef1, MtDef4 is nonmorphogenic. Studies of the mode of action of these defensins against F. graminearum demonstrated that both MsDef1 and MtDef4 defensins induced plasma membrane permeabilization; however, MtDef4 was more efficient than MsDef1. In addition to fungi, MtDef4 was also active against Gram-negative and Gram-positive bacteria [23].
The γ-cores of both MsDef1 and MtDef4 defensins differ significantly in the amino acid sequences and the net charge (Table 3): +3 for MsDef1 and +6 for MtDef4. Both defensins possess a hydrophobic residue (Phe) in the γ-core region. Sagaram et al. studied structure-activity determinants in MsDef1 and MtDef4 defensins [9]. They showed that the replacement of the γ-core of MsDef1 for the γ-core of MtDef4 makes the MsDef1-γ4 variant almost as potent as MtDef4 against the fungus F. graminearum and abolishes hyperbranching characteristic of MsDef1. Different versions of the γ-core motifs of both defensins were synthesized (Table 3). Comparative analysis of the antimicrobial potency of MtDef4 γ-core variants against F. graminearum showed that (i) MtDef4 γ-core (GMA4) alone efficiently inhibited fungal growth, although the whole molecule was 3−4 times more active. (ii) The activity of the “extended” γ-core GMA4-C (with additional six residues from the C-terminus) was identical to that of the classical γ-core. (iii) The loop GMA4-L between the cysteines, which is a positively charged short peptide RGFRRR within the γ-core region, is also active, although to a lesser extent than the “classical” γ-core. (iiii) In the hexapeptide RGFRRR, Phe is important. Its substitution for Ala in GMA4-L1 dramatically decreases activity. (iiiii) Furthermore, the first Arg in this hexapeptide is also important. Its substitution for Ala in GMA4-L2 drastically decreases activity. It is worth noting that the sequence RGFRRR is found in defensins of different plant families (Poaceae, Amaranthaceae, Solanaceae, see below). Therefore, it is evolutionarily conserved.
Studies of the MsDef1 γ-core and its variants showed that (i) it was virtually inactive against F. graminearum (GMA1), although the whole molecule displayed rather potent antifungal activity. (ii) Addition of six residues to the C-terminus of the MsDef1 γ-core enhanced the antifungal activity of the MsDef1 fragment (GMA1-C) against F. graminearum compared to the classical γ-core. (iii) The loop GMA1-L between the two cysteine residues consisting of the sequence RDDFR, in contrast to the hexapeptide RGFRRR, was virtually inactive against F. graminearum.
Further studies of the role of the cationic loop RGFRRR in the mode of action of the MtDef4 defensin against F. graminearum showed that it is necessary for the defensin internalization into the cells of F. graminearum [28]. Replacement for AAAARR or RGFRAA destroys the ability of the MtDef4 defensin to enter fungal cells, demonstrating the importance of RGFR and RR sequences for this process. It was also shown that the loop RGFRRR interacts with high affinity with phosphatidic acid, a precursor of membrane phospholipids, and this interaction mediates the transport of MtDef4 into the fungal cell walls, possibly to further interact with intracellular targets.
The antifungal and antibacterial activity of the γ-core motifs of MsDef1 and MtDef4 (with six additional C-terminal residues) on other pathogens besides F. graminearum, was further studied by Sathoff et al. [23]. A special emphasis was made on the pathogens causing crown rot, which severely damaged M. sativa.
It was shown that the γ-core motif peptides of MtDef4 and MsDef1 displayed antifungal activity against crown rot pathogens in a micromolar range (Table 3). The γ-core motif of MtDef4 exhibited a wider spectrum of antifungal activity than MsDef1 γ-core. While the γ-core of MtDf4 was active against both F. oxysporum and Phoma medicaginis, the γ-core of MsDef1 was active only against P. medicaginis and inactive against F. oxysporum f. sp. medicaginis (at a concentration below 30 µg/mL) (Table 3). The antifungal activity of the γ-core from MtDef4 against P. medicaginis and F. solani was studied in more detail. It was demonstrated that this peptide suppresses spore germination, germ tube elongation, and mycelial growth. However, no morphological changes of spores or hyphae were observed.
Comparison of the activity of the full-length peptide MtDef4 with the activity of its γ-core showed that the intact defensin had higher activity against P. medicaginis and F. oxysporum f. sp. medicaginis than its γ-core (Table 3). Regarding the mode of action, the full-length defensin similar to the γ-core, induced inhibition of spore germination and hyphal growth.
In the same study, in addition to the antifungal activity, the antibacterial activity against plant and human pathogens of the γ-cores of the defensins MsDef1 and MtDef4 was also assayed [23]. The γ-core of MtDef4 displayed more potent antibacterial activity than the MsDef1 γ-core against Pseudomonas syringae pv. syringae but was less active against Xanthomonas alfalfae subsp. alfalfae (Table 3). Similarly to the antifungal activity, the activity of the full-length MtDef4 against P. syringae pv. syringae was much higher than that of its γ-core peptide. Against X. alfalfae subsp. alfalfae, the intact MtDef4 was also more potent than its γ-core.
Sathoff et al. also tested the activity of the γ-core of MtDef4 against four human bacterial pathogens: Serratia marcescens, Enterobacter aerogenes, Enterococcus casseliflavus, Pseudomonas aeruginosa [23]. The peptide was inactive at tested concentrations against Enterococcus casseliflavus and was highly active against Enterobacter aerogenes (IC50 = 2.3 µM) and P. aeruginosa (IC50 = 2.7 µM). Studies of the mode of action of MtDef4 γ-core against Pseudomonas species showed that MtDef4 γ-core damages bacterial OM leading to the production of pores [27]. It was also suggested that the MtDef4 γ-core antibacterial mode of action involves inhibition of translation.
The effect of MsDef1, MtDef4, and peptides derived from their γ-core motifs was also studied during colony initiation in the fungus Neurospora crassa [26]. It was shown that MsDef1 and MtDef4 and their peptides inhibited the germination of conidia and accompanying cell fusion in N. crassa with different efficiencies (Table 3). The hexapeptide RGFRRR derived from the γ-core motif of MtDef4 selectively inhibited cell fusion. It was demonstrated that MsDef1, MtDef4, and their peptides disturbed Ca2+ homeostasis, however, in distinct ways.
In addition to the γ-core motifs, MsDef1 and MtDef4 possess the α-core motifs (Table 3, Figure S1). In contrast to the γ-cores, they are not positively charged. Antifungal assays clearly demonstrated that the α-core motifs of both defensins did not exhibit antifungal activity against F. graminearum (IC50 > 48 µM) [9].

2.4. MtDef5 (Fabaceae)

MtDef5 is a highly cationic bi-domain defensin encoded by a single gene in the genome of the legume M. truncatula, which is predicted to be apoplast-located. It displays potent activity against a variety of filamentous fungi, being one of the most potent broad-spectrum antifungal defensins expressed in M. truncatula. It is 8 and 32 times more powerful growth inhibitor of F. graminearum than MtDef4 and MsDef1 [29]. Each domain of MtDef5 consists of 50 amino acid residues, which are connected by a 7-amino acid linker (Table 4). The net charge of MtDef5 is +16, and the net charge of its subunits is +7 for MtDef5A and +8 for MtDef5B. The γ-cores of the two subunits differ from each other by a single amino acid residue: Phe in MtDef5A is substituted with Ile in MtDef5B and are quite different from the γ-cores of MsDef1 and MtDef4 (Table 4, Figure S1). The antifungal activity of MtDef5 against F. graminearum is higher than that of individual subunits MtDef5A and MtDef5B (Table 4). Studies of the mode of action of this defensin showed that it induces membrane permeabilization and accumulation of ROS in both F. graminearum and N. crassa hyphae, which contributes, at least partially, to fungal growth arrest [29]. However, the internalization mechanisms of the defensin in N. crassa and F. graminearum are different. MtDef5 was shown to bind to several phospholipids in fungal membranes, mainly phosphatidylinositol monophosphates, and form oligomers in their presence, whereupon it enters the fungal cells and moves to the nucleus, intracellular membranes, and other subcellular compartments leading to their degradation. The role of different amino acid residues of the γ-cores in membrane permeabilization, lipid-binding, and antifungal activity was explored by substituting two adjacent residues in the γ-core of MtDef5 subunits with alanine [29]. The results showed that histidine and arginine residues present in the γ-core motif of each domain, His36, and Arg37 in MtDef5A and His93 and Arg94 in MtDef5B, are critical for oligomerization and antifungal activity of MtDef5; however, the antifungal activity of MtDef5 did not correlate with its ability to bind phospholipids.
The activity of MtDef5 defensin and the γ-core-containing region of MtDef5A was also studied against M. sativa crown rot pathogens (Table 4) [23]. MtDef5 was found active against F. oxysporum f. sp. medicaginis and P. medicaginis with IC50 values of 0.8 and 1.3 µM (for two F. oxysporum strains) and 1.5 and 1.6 µM (for two P. medicaginis strains). The γ-core containing peptide of MtDef5A was active only against P. medicaginis with IC50 values of 19.5 and 8.5 µM for two pathogen strains. Thus, the activity of the core peptide was lower than that of the full-length defensin. The γ-core of MtDef5A was also active against F. solani (IC50 = 4.1 µM).
The γ-core of MtDef5A, such as that of MtDef4, inhibited spore germination, germ tube elongation, and mycelial growth in P. medicaginis and F. solani without causing morphological changes of spores or hyphae [23].
In addition to the antifungal activity, MtDef5 and its subunits display antibacterial activity. It was shown that MtDef5 inhibits the growth of the plant bacterial pathogen—the Gram-negative bacterium Xanthomonas campestris but was ineffective against the Gram-positive Clavibacter michiganensis and C. insidiosus, possibly due to the inability of MtDef5 to cross the outer layer of peptidoglycan present in their cell walls [23,30]. The MtDef5B subunit exhibited more potent antibacterial activity than its parent bi-domain MtDef5 and MtDef5A subunit. MtDef5 and each of its two subunits trigger distinct morphological changes in X. campestris followed by bacterial cell death. They permeabilize the bacterial plasma membrane and translocate to the cytoplasm, bind to negatively charged DNA, and possibly kill bacterial cells by inhibiting DNA synthesis and/or transcription. The cationic amino acids (His36, Arg37, His96, and Arg97) present in the two γ-core motifs of MtDef5 that were shown to be essential for its antifungal activity are also important for its antibacterial activity (Table 4) [29].
Testing of the antibacterial activity of the γ-core of MtDef5A against the plant bacterial pathogens X. alfalfae subsp. alfalfae and P. syringae pv. syringae showed that the peptide was active against P. syringae pv. syringae (IC50 = 4.5 µM) and inactive against X. alfalfae subsp. alfalfae at a concentration of 30 µg/mL [23]. Note that the entire MtDef5 was also active only against P. syringae pv. syringae (IC50 = 0.1 µM) (Table 4).
Determination of the antibacterial activity of the γ-core of MtDef5A against four human bacterial pathogens: S. marcescens, Enterobacter aerogenes, Enterococcus casseliflavus, and P. aeruginosa showed that at tested concentrations, it was inactive only against Enterococcus casseliflavus and was highly active against Enterobacter aerogenes (IC50 = 2.8 µM) [23]. The activity against two other bacterial pathogens was also high (Table 4).
Studies of the mode of antibacterial action of MtDef5A γ-core-containing peptide on P. aeruginosa showed that in contrast to MtDef4 γ-core, MtDef5 γ-core did not cause considerable OM damage in the pathogen [27]. MtDef5 γ-core likely interacts with intracellular targets in sensitive pathogens.

2.5. PvD1 (Fabaceae)

Mello et al. studied the antifungal defensin PvD1 from Phaseolus vulgare seeds [31]. The defensin exhibited antifungal activity against yeasts (Table 5). Four peptides based on the γ-core sequence of PvD1 were synthesized: two peptides 15 amino acids long (γ31-45PvD1 and γ31-45PvD1++) and two peptides nine residues long (γ33-41PvD1 and γ33-41PvD1++) (Table 5, Figure S1). Both 15-mer peptides, in addition to the γ-core motif, contained two more residues from the N-terminus and four residues from the C-terminus. Note that PvD1 γ-core was identical to that of MsDef1. In all four peptides, cysteine residues were substituted with alanine to prevent the formation of disulfide bonds [31]. In one peptide of each pair, two negatively charged Asp residues were substituted with two Arg. The antifungal activity of the γ-core-containing peptides was assayed against two yeast species, C. albicans, and C. buinensis. The antifungal assays with the long peptides γ31-45PvD1 and γ31-45PvD1++ showed that yeast growth inhibition was considerably improved by substituting Asp with Arg, especially for C. buinensis. Complete inhibition was observed at a concentration of 73.4 µM for C. albicans and 18.35 µM for C. buinensis.
The antifungal assays with the short peptides γ33-41PvD1 and γ33-41PvD1++ demonstrated that inhibition of both yeasts by a non-modified peptide γ33-41PvD1 was poor [31]. The DD/RR substitution enhanced the degree of inhibition, especially for C. buinensis. Complete inhibition of C. buinensis was achieved at the γ33-41PvD1++ concentration of 36.7 µM. C. albicans was inhibited by all tested peptide concentrations. However, even at the highest concentration of 293.6 µM, only 63% inhibition was reached.
The mode of action of the short peptide γ33-41PvD1++ was further studied against a more sensitive yeast species C. buinensis [31]. It was shown that C. buinensis cells lost their viability in the presence of the peptide. Treatment of C. buinensis cells with γ33-41PvD1++ at a concentration of 73.4 µM resulted in a 100% loss of viability, demonstrating that the peptide exerted a fungicidal effect on this pathogen.
At a concentration below MIC (25 µM), γ33-41PvD1++ caused membrane permeabilization [31]. The peptide also induced oxidative stress manifested by ROS production, dysfunction of mitochondria, and activation of metacaspases. It was suggested that yeast killing occurred due to programmed cell death via an apoptotic pathway.
Thus, the authors concluded that (i) the longer peptides extending beyond the γ-core motif of PvD1 have higher antifungal activity than the shorter ones. This observation means that not only the γ-core motif is responsible for the antifungal properties of defensins, but the surrounding residues are also involved. (ii) Increasing the net positive charge of the γ-core-containing peptides enhances their antifungal potency.

2.6. VuDef1 (Fabaceae)

Toledo et al. studied the activity of the VuDef1 defensin from cowpea Vigna unguiculata [32]. This defensin, in combination with an LTP, displayed inhibitory activity against filamentous fungi, Leishmania amazonensis, and insect α-amylases [33,34,35]. A synthetic peptide A36,42,44γ32–46VuDef named DD corresponding to the γ-core of this defensin with three cysteines replaced with alanine, and its variants were produced (Table 6, Figure S1) [32]. Note that the γ-core of VuDef1 was identical to the PvD1 γ-core except for the Val/Phe substitution. In order to increase the positive charge of the γ-core peptide, in one variant A36,42,44R37,38γ32–46VuDef named RR, two Asp residues were substituted with two Arg residues. In the second variant D-A36,42,44R37,38γ32–46VuDef named D-RR, the sequence was the same as in RR, but all amino acids were D-enantiomers to reduce protease degradation and mammalian cell toxicity. In the third variant, designated A42,44R37,38W36,39γ32–46VuDef and named WR, tryptophan residues instead of Ala36 and Val39 residues were introduced (the numbering of amino acid residues is given as in the original article [32]). Tryptophan residues in AMPs interact with high efficiency with membranes of pathogenic microorganisms, and their incorporation into the designed AMP sequence increases its antimicrobial potency [36]. A synthetic peptide DD showed activity on the parasite L. amazonensis similar to that of Vu-Def (Table 6). The interaction between DD and L. amazonensis resulted in parasite inhibition by the activation of an apoptotic-like cell death pathway [37]. The γ-core-based peptides were also assayed against five Candida species (C. albicans, C. buinensis, C. parapsilosis, C. tropicalis and C. pelliculosa) and S. cerevisiae (Table 6) [32]. The DD peptide showed no activity against yeasts. In contrast, RR peptide at a concentration of 18.5 µM inhibited the growth of C. albicans, C. buinensis, and C. tropicalis by 47.5, 100, and 72.1%, respectively; however, S. cerevisiae, C. parapsilosis, and C. pelliculosa were insensitive to the peptide. D-RR at a concentration of 18.5 µM inhibited the same Candida species as RR, however, with greater efficiency. The authors suggest that higher potency of D-RR could be associated with higher resistance to protease degradation [32]. The peptide WR, which was the most hydrophobic and cationic of all tested peptides, had the highest activity on the sensitive yeast species. It inhibited the growth of S. cerevisiae, C. albicans, C. buinensis, and C. tropicalis by 26.1, 96.2, 98.5, and 58.2%, respectively, although it was unable to suppress the growth of C. parapsilosis and C. pelliculosa. The MIC values for inhibition of C. albicans by D-RR peptide and WR were 23 µM and 18.5 µM, respectively. Thus, the designed peptides were more potent against the sensitive yeast species than the original DD peptide.
The peptides displayed fungicidal activity on the tested yeasts [32]. The lethal dose (LD100) values for C. albicans were 36.5 μM for D-RR and 27.5 μM for WR. All peptides, especially WR, were found non-toxic for mammalian cells (human monocytes and murine macrophages) at concentrations below 50 µM.

2.7. DefSm2-D (Asteraceae)

A cDNA was cloned from Silybum marianum flower buds. It encoded a putative antimicrobial protein DefSm2 of 95 amino acids containing an N-terminal defensin domain (DefSm2-D) and a C-terminal Arg-rich and Lys-rich domain [38]. The defensin DefSm2-D showed 84% sequence identity with the antifungal defensin DmAMP1 from Dahlia merckii seeds, which inhibited the growth of F. solani, F. culmorum, N. crassa, and S. cerevisiae [39]. The γ-core motif of DefSm2-D is identical to that of DmAMP1. Four short peptides originating from the γ- and α-core motifs of DefSm2-D were synthesized (Table 7) [38]. SmAPα1-21 included the N-terminal region of the defensin molecule, and the α-core motif followed by glycine. SmAPα10-21 was a shorter peptide containing only the α-motif with two additional residues from the N-terminus and one glycine from the C-terminus. SmAPγ27-44 contained the γ-core motif with six additional residues from the N-terminus, while SmAPγ29-35 was the shortest peptide of all, containing only GAC from the γ-core motif and four additional residues from the N-terminus. CD spectra showed that the peptides were predominantly in a random coil conformation.
Peptide SmAPγ29-35 at concentrations up to 100 µM did not show any activity against F. graminearum. Three other peptides were active: the activity of the longer peptide was higher than that of the shorter one. MIC values were 32 µM for SmAPα1-21, 70 µM for SmAPα10-21, and 20 µM for SmAPγ27-44. All three active peptides contained a tryptophan residue which plays a crucial role in the interactions with membranes, anchoring the peptide at the membrane interface [36].
Studies of the mode of action of the active peptides showed that all three peptides induced membrane permeabilization of F. graminearum conidia as judged by propidium iodide uptake. In the presence of the α-core-derived peptides macroconidia aggregated into network-like clusters. Clusters were not formed with the SmAPγ27-44 peptide. Transmission electron microscopy showed that SmAPα1-21, in contrast to SmAPγ27-44, induced granulation of the cytoplasm. Both in the presence of SmAPα1-21 and SmAPγ27-44, the appearance of a large number of peroxisomes was recorded. The results obtained indicated that the mode of action of α-core-derived peptides is different from that of γ-core-derived peptides.

2.8. Atr-DEF2 (Amaranthaceae)

Moyer et al. studied the mode of antibacterial action of the γ-core motif peptide from the predicted defensin Atr-DEF2 of Amaranthus tricolor [40]. In Atr-DEF2, the γ-core motif is identical to that of MtDef4 (Figure S1). The peptide Atr-DEF2(G39-C54) spanning the γ-core and the C-terminal residues except for the C-terminal Ala of Atr-DEF2 was synthesized (Table 7), and its activity against the Gram-negative human pathogenic bacteria Escherichia coli and Klebsiella pneumoniae was assayed [40]. The γ-core motif peptide was much more active against E. coli (IC50 = 9 μM) than against K. pneumonia (IC50 = 68 μM). The proteomic changes in E. coli induced by Atr-DEF2(G39-C54) were explored using label-free quantitative proteomics, and it was discovered that of the 1598 proteins, the abundance of 51 proteins decreased, and the abundance of 82 proteins increased. It was found that six proteins involved in the lipid A aminoarabinose modification pathway displayed increased abundance in Atr-DEF2(G39-C54)-treated E. coli cells. This suggests that E. coli was up-regulating signaling related to OM stress response. Furthermore, proteomics analysis demonstrated that the peptide Atr-DEF2(G39-C54) triggered iron deficiency. In vitro assays proved that it reduced the concentration of aqueous Fe3+ and chelated Fe2+. Accordingly, Atr-DEF2(G39-C54) influenced the composition of the OM and iron homeostasis in the pathogen, which reacted to OM and iron deficiency stress.

2.9. Spinach So-D2 (Amaranthaceae)

Seven defensins So-D1−7 were isolated from Spinacia oleraceae leaves [41]. The So-D2 was completely sequenced. Antimicrobial assays showed that So-D2 was highly active against plant pathogenic bacteria and fungi: C. michiganensis, Ralstonia solanacearum, F. culmorum, and F. solani [41]. The defensin was also shown to be highly active against human pathogens, including multidrug-resistant (MDR) strains of P. aeruginosa and C. albicans [42]. It also inhibited MDR strains of E. coli and Klebsiella pneumonia, although less effectively. The So-D2 was shown to inhibit biofilm formation in MDR P. aeruginosa and C. albicans. Studies of the mode of action of the defensin demonstrated that it disturbed the integrity of the cell membranes of P. aeruginosa and C. albicans [42].
The modified γ-core motif peptide of So-D2 defensin with an extension of six amino acid residues and Cys/Leu substitution at the C-terminus was synthesized and assayed against the fungal and bacterial alfalfa crown rot pathogens (Table 7) [23]. The peptide was found active against F. oxysporum f. sp. medicaginis with IC50 of 33.1 μM and highly active against two P. medicaginis strains with IC50 values of 6.4 and 6.1 μM (Table 7). The peptide also efficiently suppressed the growth of F. solani (IC50 = 13.8 μM). The So-D2 γ-core peptide inhibited the growth of the bacterial pathogens X. alfalfae subsp. alfalfae (IC50 = 19.3 μM) and P. syringae pv. syringae (IC50 = 25.9 μM), although the γ-core peptide of MtDef4 was more potent (see above).

2.10. BcDef (Solanaceae)

A defensin gene BcDef was cloned from Brugmansia x candida, a medicinal ornamental plant [43]. The predicted BcDef defensin shares high sequence similarity (78−85%) with Solanaceae class 1 defensins. The BcDef defensin has both the γ- and α-core motifs. The γ-core-containing peptide BcDef1 consisting of 17 amino acid residues (net charge of +4) of this defensin was synthesized (Table 7) [43]. The peptide displayed inhibitory activity against Gram-positive and Gram-negative bacteria with MIC values from 15 to more than 251 µM (Table 7). The highest activity (MIC = 15.7 µM) was observed against Staphylococcus epidermidis. Moderate activity (MIC = 31.4 µM) was recorded against S. typhimurium. The activity against other pathogens (Vibrio cholera, Shigella sonnei, E. coli, Enterococcus faecalis, Bacillus cereus, S. aureus) was lower (Table 7). It was shown that BcDef1 kills S. epidermidis cells by triggering membrane and cell wall damage, including alteration of the membrane potential and permeability without cytotoxicity to normal mammalian cells [43]. In addition to antimicrobial properties, the peptide displayed antioxidant activity.

2.11. Tomato SolyC07g007760 (Solanaceae)

A very similar to the γ-core peptide BcDef1, a 17-mer peptide named SolyC, was synthesized by Rigano et al. [44]. It encompassed the γ-core region of a tomato defensin SolyC07g007760 (Table 8, Figure S1). The antibacterial activity of SolyC against important human pathogens was assayed [44]. At a low peptide concentration, SolyC showed antimicrobial activity against the Gram-negative bacteria Salmonella enterica serovar Paratyphi, E. coli, and Helicobacter pylori (MIC = 15 µg/mL). At a higher concentration, it also inhibited the growth of the Gram-positive bacteria S. aureus, S. epidermidis, and Listeria monocytogenes (MIC = 40 µg/mL). Meanwhile, SolyC displayed very low antibacterial activity against the probiotic bacteria Lactobacillum plantarum and L. paracasei.
The peptide showed very low (< 5%) hemolytic activity and had no cytotoxic effects at concentrations from 60 to 120 µg/mL against THP-1 human acute monocytic leukemia cells [33]. In addition, the SolyC peptide displayed anti-inflammatory activity in vitro by down-regulating the level of the proinflammatory cytokines TNF-α and IFN-γ. Thus, for this γ-core peptide, a dual function as an antimicrobial and anti-inflammatory agent was demonstrated.
In the following study, several derivatives of SolyC were produced, and their antibacterial activity against the Gram-positive (S. aureus, S. epidermidis, L. monocytogenes) and Gram-negative bacteria (H. pylori and S. enterica) was studied [45]. These peptides included: a linear SolyC, a truncated linear SolyC-t, lacking three amino acids from the N-terminus, SolyC1, in which the third Cys was replaced by Ser, a truncated SolyC1-t, SolyC2, in which Cys2 was replaced by Ser, truncated SolyC2-t, and oxidized forms of these peptides—SolyC1-ox, SolyC1-t-ox, SolyC2-ox, and SolyC2-t-ox, with a single disulfide bond each. The antimicrobial activity (MIC100) of all the peptides was in the range from 10 to 100 µg/mL (Table 8).
It was shown that, in general, the peptides were more active against the Gram-negative bacteria than against Gram-positive bacteria (Table 8) [45]. Linear peptides were more active than their truncated forms. For the intact SolyC, truncation resulted in the reduction in activity against the Gram-positive Staphylococcus spp. However, no differences in activity against the Gram-negative bacteria were observed (Table 8). Against L. monocytogenes, all modified peptides had the same antimicrobial activity (MIC100 = 80 µg/mL) as SolyC. Linear peptides with two cysteines, SolyC1 and SolyC2, showed reduced activity compared to SolyC against the Gram-positive Staphylococcus spp. All oxidized peptides were highly active against the Gram-negative bacteria (MIC100 = 15−20 µg/mL). The linear peptide SolyC2 displayed the same antimicrobial activity against the Gram-negative bacteria as the original peptide SolyC, whereas the linear SolyC1 was less active. The activity of all modified peptides against the Gram-positive bacteria was, in all cases, lower than that of SolyC. The authors suggest that the interaction of the peptides with the membranes of Gram-negative bacteria is stronger when the positive charges are exposed, which is observed when the peptides are in the oxidized form. Thus, the formation of an intramolecular disulfide bond stabilized the peptides in the “active” conformation.
It was also demonstrated that all peptides up to a concentration of 90 µg/mL showed low hemolytic activity (below 30%) [44]. It was also shown that the peptide SolyC2 with high selectivity interacted with the bacterial OM.

2.12. Tomato SlDEFL2 and SlDEFL4 (Solanaceae)

In tomato transcriptomes, two defensin genes, SlDEFL1 and SlDEFL2, which were upregulated by F. oxysporum infection and fungal resistance inducers, were discovered [47]. They encoded two peptides, SlDEFL2 and SlDEFL4, which harbored nearly identical γ-core motifs [46]. Two γ-core-containing peptides named γ58-74SlDEFL2 and γ58-74SlDEFL4, respectively, were synthesized (Table 8, Figure S1). They differed by two amino acid residues at positions 2 (Ser/Thr) and 5 (Asp/Asn), resulting in a higher positive charge of γ58-74SlDEFL4 (+5 vs. +4 for γ58-74SlDEFL2). Note that DEFL-derived peptides were highly similar to SolyC. Antimicrobial activity of these two γ-core peptides was assayed against a panel of nine pathogens, including yeasts Cryptococcus neoformans and Candida albicans affecting immunocompromised individuals, plant pathogenic bacteria Clavibacter michiganensis, Pseudomonas savastanoi and Pectobacterium carotovorum, four Fusarium species, Bipolaris sorokiniana and Botrytis cinerea [46]. Both γ-core peptides were found to be highly active against yeasts, especially C. neoformans (Table 8). Both Gram-positive (C. michiganensis) and Gram-negative bacteria (P. savastanoi and P. carotovorum) were sensitive to the peptides. The IC50 for inhibition of C. michiganensis was 19.8 and 21.5 µM for γ58-74SlDEFL2 and γ58-74SlDEFL4, respectively. At the highest tested concentration of 300 µM, a positive correlation between the net charge and inhibitory activity against bacteria was observed: γ58-74SlDEFL4 was more efficient than γ58-74SlDEFL2. For γ58-74SlDEFL4, the degree of inhibition varied from 100% against P. savastanoi to 81% against P. carotovorum, while γ58-74SlDEFL2 was less active against all tested bacteria. In contrast to bacteria and yeasts, the activity of both γ-core peptides against fungal pathogens was similar. F. verticillioides and F. solani were insensitive to γ58-74SlDEFL2 and γ58-74SlDEFL4 at all tested concentrations, while IC50 for inhibition of F. culmorum was 44.8 and 42.3 µM and IC50 for inhibition of F. oxysporum was 165.8 and 124.8 µM, respectively. B sorokiniana appeared to be insensitive to γ58-74SlDEFL2 and γ58-74SlDEFL4; conversely, B. cinerea was inhibited by 31–45% at the highest tested concentration. Studies of the mode of action of the highly active peptide γ58-74SlDEFL4 on C. albicans cells using staining with propidium iodide showed that the peptide induced membrane permeabilization suggesting that membrane disruption might be the cause (or one of the causes) of the pathogen killing [46].

2.13. HsAFP1 (Saxifragaceae)

HsAFP1 is a defensin from seeds of coral bells Heuchera sanguine, which is active against plant pathogenic fungi, such as B. cinerea, Verticillium albo-atrum, and F. culmorum [39]. It is also active against Saccharomyces cerevisiae and C. albicans, inducing apoptosis and preventing biofilm formation in C. albicans. HsAFP1 acts synergistically with caspofungin and amphotericin B against C. albicans planktonic cells and biofilms [48]. Six 24-mer synthetic peptides with 18-mer overlap spanning the entire HsAFP1 sequence were synthesized, and their activity towards F. culmorum and C. albicans planktonic cultures and biofilms was studied (Table 9) [48]. Cysteine residues were replaced by α-aminobutyric acid. Peptides 5 and 6 encompassed the γ-core signature. Peptide 5 included the γ-core and 12 residues from the N-terminus of the γ-core, while peptide 6 covered the γ-core sequence with six additional residues from the N- and C-termini. Peptides 1−3 harbored the α-core motif. None of the linear fragments inhibited the growth of F. culmorum up to the highest tested concentration of 1.5 μM, while the recombinant HsAFP1 inhibited the growth of this pathogen with IC50 = 0.45 μM. Furthermore, the synthetic peptides did not suppress the growth of C. albicans in contrast to the full-length defensin. Only HsLin06 inhibited C. albicans biofilm formation to the same extent as the recombinant HsAFP1 (Table 9). Thus, the importance of the γ-core and its adjacent regions for antibiofilm activity was demonstrated. HsLin03 and HsLin05 also inhibited C. albicans biofilm formation. However, their efficiency was much lower than that of HsLin06 (10 or 15 times lower). Other linear peptides were inactive against C. albicans biofilms up to a concentration of 175 μM. Only three linear peptides, HsLin06, HsLin01, and HsLin05, acted synergistically with caspofungin in preventing biofilm formation [48].

2.14. Rice OsAFP1 (Poaceae)

The rice OsAFP1 defensin is highly active against the plant pathogenic fungi Pyricularia oryzae, Rhizoctonia solani, and Gibberella fujikuroi, but is inactive against bacteria, such as Burkhalderia plantarii, B. glumae, and Acidovorax avenae (Table 10) [49]. Eight 10-mer overlapping peptides covering the entire defensin sequence were synthesized (Table 10) [49]. Peptide 7 covered the γ-core motif without the GXC submotif. Peptide 8 encompassed the C-terminal part of the γ-core motif plus the C-terminal region of the defensin molecule. Peptides 1 and 2 from the N-terminal region and peptides 7 and 8 from the C-terminal region possessed antifungal activity against P. oryzae. The N-terminal peptide 1 had the highest activity (IC50 = 0.41 µg/mL), which was higher than that of the intact defensin (IC50 = 0.99 µg/mL). Peptides 2, 7, and 8 had approximately the same activity as the intact defensin (Table 10). Note that peptide 3, encompassing the α-core motif, was inactive. The obtained results indicate that activity against P. oryzae depends both on the N-terminal and the γ-core containing regions of the OsAFP1 molecule.
In addition to plant pathogenic fungi, rice OsAFP1 was found to be fungicidal to C. albicans cells (Table 10) [50]. Studies of the mode of action of OsAFP1 showed that it induces apoptosis 0.5 h after treatment. The defensin was also active against Saccharomyces cerevisiae. However, this defensin was inactive against human pathogenic bacteria, such as E. coli, Porphyromonas gingivalis, Streptococcus mutans, Staphylococcus aureus, and Propionibacterium acnes. The same eight overlapping peptides of OsAFP1, as were tested against plant pathogenic fungi, were assayed against C. albicans (Table 10). Peptides 1, 2, 7, and 8 possessed antifungal activity with IC50 = 6, 19, 10, and 13 μM, respectively. The highest activity was displayed by peptides 1 and 7. Again peptide 3 encompassing the α-core motif was inactive. Thus, the N-terminal and the γ-core containing regions of the OsAFP1 molecule are important for the antifungal activity. To identify the residues essential for antifungal activity, in the peptide 7 region of OsAFP1, six amino acid residues with voluminous side chains Lys35, His37, Leu39, Glu40, Arg41, and Lys42 were successively replaced by alanine [50]. The activities of L39A and R41A mutants were very low, indicating the vital role of these residues in antifungal activity (Table 10). Thus, the γ-core motif, especially Leu39 and Arg41, plays an important role in OsAFP1 antifungal activity.

2.15. Maize ZmESs (Poaceae)

Four genes named ZmES1−4 (Zea mays embryo sac) were isolated from the cDNA library of maize egg cells [51]. They code four highly similar defensins with sequence identity from 91% to 97%. Studies of the biological activity of ZmES1−4 peptides showed that ZmES4 induced pollen tube burst by opening the potassium channel KZM1. ZmES1−4 peptides also inhibited the germination of F. graminearum conidia and Ustilago maydis spores (Table 11) [52].
To reveal regions essential for pollen tube burst and antifungal activity of the ES peptides, five peptides (13–16 amino acids in length) named ES-a, ES-b, ES-c, ES-d, and ES-e, which covered the entire sequence of ES4, were synthesized (Table 11) [52]. Studies of the effect of ES4 and ES4-derived peptides on pollen tube burst in maize showed that the ES-d peptide encompassing the γ-core was even more active than the full-length peptide; at a concentration of 0.5 µM, the induction of pollen tube burst amounted to 82.5%. Peptides derived from other ES regions were unable to induce pollen tube burst. In order to identify amino acid residues involved in maize pollen tube burst, ES-d, and its 15 mutated derivatives were applied to germinated maize pollen. The results showed that mutations of Leu3, Ile4, or Tyr15 in ES-d inhibited pollen tube burst to less than 8%, thus pointing to the crucial role of these residues in this process. Studies of the antimicrobial effect of ES-c and ES-d on two maize pathogens, F. graminearum, and U. maydis, demonstrated that at high peptide concentrations (10–90 µM), both peptides displayed inhibitory activity, while other peptides did not. Mutations of Gly8, Tyr9, or Thr10 in ES-c; and mutations of Lys13, Cys14, or Tyr15 in ES-d significantly increased fungal germination. Thus, the γ-core region of ES4 and its neighboring residues from the N-terminus sequence is important for the antifungal activity. The mode of action of ES-d and ES-c peptides was shown to be different for different pathogens [52]. The ES-d bound only to the cell surfaces of F. graminearum, while the ES-c peptide bound to cell surfaces and accumulated inside the cells. In U. maydis, both peptides accumulated inside the cells.

2.16. Wheat TkDEFLs (Poaceae)

Eight γ-core motif peptides of the defensins TkDEFL1-11, 1-12, 1-16, 1-20, 1-23, 1-32, 1-36, and 1-40, which were predicted in the wheat Triticum kiharae during RNA-seq data analysis, were synthesized and their antimicrobial properties were explored [53]. Several γ-core peptides showed high sequence similarity (Table 12, Figure S1). The TkDEFL1-16 γ-core peptide possessed a highly basic hexapeptide RGFRRR, which was discovered in a number of defensins, including MtDef4, SolyC07g007760, SlDEFL2, and SlDEFL4. Four synthetic γ-core peptides were designed on the basis of the sequences of 4-Cys-containing defensins TkDEFL4-4, 4-8, 4-20, and 4-37. In addition to the full-length TkDEFL4 γ-core peptides, their shortened versions were also synthesized. These truncated variants represented the loops between the second and the third cysteine residues with or without the adjacent cysteine residues (Table 12). HvDEFL4-167-77, corresponding to the loop between the second and the third cysteines in barley HvDEFL4-1, was also synthesized.
The synthetic peptides were assayed against nine pathogens, including the yeasts affecting humans, plant pathogenic bacteria, and fungi: Candida albicans, Cryptococcus neoformans, Clavibacter michiganensis, Pseudomonas savastanoi, Pectobacterium carotovorum, and four Fusarium species (F. oxysporum, F. culmorum, F. solani, and F. verticillioides) [53]. All tested peptides displayed antimicrobial properties (Table 12). As expected, their activity varied depending on the pathogen. Most γ-cores of classical defensins displayed high antimicrobial activity against the vast majority of the pathogens tested. The most active peptide was TkDEFL1-1665-82. The IC50 values for inhibition of the yeasts by this peptide were 4.4 µM and 14.6 µM for C. neoformans and C. albicans, respectively. IC50 for inhibition of the Gram-positive bacterium C. michiganensis was 14.6 µM, 12.1 µM, and 20.7 µM for the fungi F. oxysporum and F. culmorum, respectively. The high antimicrobial potency of TkDEFL1-1665-82 might be associated with its highest net charge at neutral pH (+5) compared to other peptides. The least active γ-core peptide designed from the sequences of the classical defensins was the peptide TkDEFL1-1155-68. Remarkably, one of the most active peptides, TkDEFL1-3255-68 differed from the least active TkDEFL1-1155-68 by two amino acid residues (IS in TkDEFL1-1155-68 is replaced by FR in TkDEFL1-3255-68), which increases the net charge of TkDEFL1-3255-68. Thus, FR is vital for the antimicrobial potency of TkDEFL1-3255-68. Comparison of the antimicrobial properties of two γ-core motif peptides TkDEFL1-2365-82 and TkDEFL1-4065-82, which differ by a single residue (Y13F) between the second and the third cysteines showed that they are very similar pointing to the minor role of this substitution for antimicrobial activity.
Studies of the antimicrobial activity of seven peptide fragments of 4-Cys-containing defensins showed that all of them suppressed the growth of yeasts, however, the efficiency of inhibition varied, and usually, the activity of the longer peptides was higher than that of the truncated variants [53]. For example, TkDEFL4-2086-110 was more potent than TkDEFL4-2092-102, and TkDEFL4-3790-102 was more efficient than TkDEFL4-3791-101 in suppressing the growth of C. neoformans (Table 12). TkDEFL4-3790-102 was also more effective in inhibiting the growth of P. savastanoi and P. carotovorum. Furthermore, the peptide TkDEFL4-2086-110 exhibited the highest activity of all peptides against C. michiganensis at 300 µM (91% inhibition), and TkDEFL4-3790-102 was the most effective against P. savastanoi. We can hypothesize that for the inhibition of these pathogens, oligomerization of the peptides via disulfide bond formation is required. Against F. culmorum, the highest activity (60% inhibition at 150 µM) was displayed by TkDEFL4-2086-110. The same peptide was the most potent against F. oxysporum (54% inhibition at 150 µM). In contrast to the activity against yeasts and bacteria, no positive correlation was observed between the length of the peptide fragment and its activity against all Fusarium fungi.
The mode of action of the γ-core peptides TkDEFL1-1665-82, TkDEFL1-3255-68, TkDEFL4-2086-110, TkDEFL4-3790-102 and HvDEFL4-167-77 on C. albicans and C. neoformans cells was studied by fluorescent microscopy. The results clearly demonstrated that all tested peptides induced membrane permeabilization leading to the accumulation of the fluorescent dye inside the yeast cells.

2.17. Olive tree OefDef1.1 (Oleaceae)

OefDef1.1 is a highly cationic His- and Tyr-rich Olea europaea defensin with a high percentage of hydrophobic residues, which belongs to the Oleaceae-specific defensin subfamily [10]. OefDef1.1 inhibits the growth of B. cinerea, F. graminearum, F. oxysporum, and F. virguliforme (Table 13). Surface application of the peptide on Nicotiana benthamiana and lettuce leaves, followed by inoculation with B. cinerea conidia, resulted in reduced gray mold symptoms. Studies of the mode of action of OefDef1.1 showed that the peptide rapidly permeabilized the plasma membrane of the conidia and germlings of B. cinerea. The latter were more sensitive to the peptide’s action.
The γ-core of OefDef1.1 is quite different from those of other defensins (Table 13, Figure S1) [10]. In order to elucidate its role in the antifungal activity of OefDef1.1, two OefDef1.1 variants were generated: in one, named OefDef1.1_V1, the γ-core motif was replaced by that of MtDef4, in another OefDef1.1_V2 variant, by the core motif of DmAMP1 from Dahlia merckii (Table 13). Note that the sequence of OefDef1.1 has a certain sequence similarity with DmAMP1. However, the sequence of the γ-core is different. The antifungal activity of both peptide variants against B. cinerea and F. oxysporum was assayed. The variant OefDef1.1_V1 with the γ-core of MtDef4 lost 50% activity compared to the wild-type peptide (Table 13). In contrast, the activity of the second variant was slightly higher than that of the wild-type OefDef1.1. Although the variant OefDef1.1_V1 was less active in vitro than the wild-type peptide, it was the most effective in reducing lesions caused by B. cinerea on detached N. benthamiana and lettuce leaves, namely, the peptide with a higher net charge was more effective than the peptide with a lower charge. The other conclusion was that in vitro antifungal activity does not always correlate with in planta activity.
In order to identify the residues important for the antifungal activity, alanine scanning mutagenesis of the sequence between the two cysteines in the γ-core motif of OefDef1.1 was performed [10]. Three variants designated OefDef1.1_V3 (with three neighboring N-terminal amino acid residues replaced with alanine), OefDef1.1_V4 (with the next three residues replaced with alanine), and OefDef1.1_V5 (with four C-terminal residues replaced with alanine) were obtained (Table 13). None of the variants lost in vitro antifungal activity. The activity of OefDef1.1 variants was similar to that of the wild-type peptide. Thus, specific amino acids within the γ-core motif are not critical for the antifungal activity of OefDef1.1. Hydrophobicity rather than the net charge may be a more significant contributor to the antifungal activity of this peptide.

3. Non-Defensin γ-Cores

In addition to the γ-core motif peptides of defensins, the γ-core motif peptides designed from the CRPs belonging to non-defensin families were also studied [46,53]. Three peptides, γ48-65SlSN2, γ89-106SlSN9 and γ47-64SlSN10, corresponded to the γ-core-containing regions of tomato snakins SlSN2, SlSN9, and SlSN10, and one peptide TkSN139-57 to that of the wheat snakin TkSN1 (Table 14). All the snakin γ-core peptides were positively charged (net charge of +4 and +7) and hydrophilic. However, in contrast to defensin γ-core peptides, they did not adopt a β-hairpin conformation in the snakin 3D structure, which was predicted to lack β-structure and resemble a large hairpin consisting of two α-helices [46]. All the γ-core peptides of snakins possessed potent antimicrobial activity against plant and human pathogens. Among all tested tomato and wheat γ-core peptides, they showed the highest inhibitory activity and the broadest antimicrobial spectrum [46,53]. The wheat snakin γ-core peptide TkSN139-57 was especially active against C. neoformans (IC50 = 6.0 μM) and C. michiganensis (IC50 = 12.0 μM). Of Fusarium species, TkSN139-57 effectively inhibited F. culmorum (IC50 = 27.5 μM). The tomato snakin-derived peptides γ48-65SlSN2 and γ89-106SlSN9 were even more effective against C. neoformans (IC50 = 4.2 and 5.1 μM, respectively) than TkSN139-57. C. michiganensis was also efficiently suppressed by these tomato peptides (Table 14). Fusarium species were more effectively inhibited by γ48-65SlSN2 (IC50 from 42.1 to 152.0 μM), although γ89-106SlSN9 and γ47-64SlSN10 were also highly active against particular Fusarium species. To study the mode of action of the snakin γ-core peptides γ89-106SlSN9 and TkSN139-57, staining of C. albicans and C. neoformans cells with propidium iodide in the presence of these peptides was carried out, and analyzed by fluorescence microscopy [46,53]. It was shown that the peptides caused the permeabilization of the fungal membranes.
Analysis of the antimicrobial activity of the tomato and wheat nsLTP-derived peptides γ56-72SlLTPg2.4, γ53-69SlLTPg2.5, γ70-86SlLTPg2.8, TkLTPd5.659-75, and TkLTP2.2550-62 showed that most of them were either inactive or displayed weak antimicrobial activity against the tested pathogens [46,53]. Only TkLTP2.2550-62 efficiently inhibited C. neoformans (IC50 = 45 μM). Low activity of the γ-cores of nsLTPs correlates with the negative charge or the absence of charge in the nsLTP-derived peptides (Table 15). The lack of antimicrobial activity in most nsLTP-derived peptides points to their signaling functions in the immune response.
The MEG (Maternally Expressed Gene)-derived peptide γ92-104SlMEG2 nearly completely inhibited the growth of C. neoformans and C. michiganensis at a high peptide concentration of 300 μM (Table 16) [46]. Since the role of MEG peptides in plant physiology is largely unknown, the discovery of antimicrobial activity in γ92-104SlMEG2 indicates their role in defense as antimicrobial agents.
The antimicrobial properties of the γ-core-containing peptides WAMP-G1 and WAMP-G2 of the wheat hevein-like peptide WAMP-2 were also explored [54]. The sequence of WAMP-G2 included the γ-core in D-isoform GFCGSGDAYC and four amino acid residues located N-terminally to the γ-core (Table 17). WAMP-G1 encompassed a putative γ-core in L2-isoform CGKYGFC, two N-terminal and three C-terminal amino acid residues. WAMP-G1 contained two antiparallel β-strands with an interposed turn region postulated to be a characteristic feature of the γ-core multidimensional signature [54]. In addition to the γ-core motif, the longer peptide WAMP-G2 contained all three aromatic residues of the chitin-binding site, while WAMP-G1 only had two residues (Tyr22 and Phe24).
The WAMP-2-derived γ-core peptides were assayed against seven fungal pathogens of plants, including B. sorokiniana, A. alternata, Cladosporium cucumerinum, Parastagonospora nodorum, and three Fusarium species (F. oxysporum, F. culmorum, F. avenaceum) (Table 17) [54]. WAMP-G2 inhibited the growth of all tested fungi, with B. sorokiniana and A. alternata being the most sensitive species. A comparison of the antimicrobial potential of WAMP-G1 and WAMP-G2 showed that the latter peptide was more active than WAMP-G1 against all tested pathogens. Taken that WAMP-G2 differed from WAMP-G1 by four amino acid residues from the C-terminus, including a conserved residue of the chitin-binding site Tyr31, this result shows that all three conserved aromatic residues of the chitin-binding site contribute to the antifungal activity of WAMP-G2.
In addition to antifungal activity, the ability of the γ-core peptides to increase the antifungal effect of the fungicide tebuconazole was assayed [54,55]. Treatments with the fungicide combined with WAMP-2 γ-core peptides inhibited spore germination of B. sorokiniana, A. alternata, A. solani, F. culmorum, F. avenacenum, F. oxysporum, and P. nodorum at a much greater level than the fungicide alone (except a combination of WAMP-G1 with tebuconazole against A. alternata), and the type of interactions between the fungicide and the peptides was either synergistic or additive, depending on the target fungus and concentration combinations. Compared to WAMP-G1, WAMP-G2 was shown to be a more active sensitizing fragment, synergistically enhancing the effect of sub-fungicidal tebuconazole dosages against all pathogens.

4. Discussion

Identification of molecular determinants of antimicrobial activity in AMPs is of vital importance for elucidation of their mode of action, which in turn is necessary for practical use in agriculture and medicine. In our review, we combined the available data regarding the activities of the γ-core peptides of different plant AMPs. Some γ-core sequences are widespread in defensins of a particular plant family. For example, the MsDef1 γ-core from the M. sativa defensin has close homologs in the Fabaceae family (VuDef1 and PvD1) (Figure S1). However, some γ-core sequences occur in AMPs of plants belonging to different families. The most spectacular example is the MtDef4 γ-core sequence found in defensins of Fabaceae, Solanaceae, Amaranthaceae, and Poaceae plants.
The results presented confirm the antimicrobial potential of the γ-core peptides derived from plant AMPs. This follows from the direct determination of their antimicrobial activity (Table 1, Table 2, Table 3, Table 4, Table 5, Table 6, Table 7, Table 8, Table 9, Table 10, Table 11, Table 12, Table 13, Table 14, Table 15, Table 16 and Table 17). Many γ-core peptides display activity not only against plant pathogens but against human pathogens as well, making them promising leads for pharmaceutical purposes. Antimicrobial assays showed that just as AMPs differ in their antimicrobial activity, so do their γ-cores.
Comparison of the antimicrobial activity of the γ-core peptides with that of the whole AMP molecules shows that γ-core peptides are, in the vast majority of cases, several-fold less active. Only single peptides, such as peptide 7 of OsAFP1, were claimed to exhibit the same efficiency as the parent peptide [49]. The reduced activity of the γ-core peptides compared to the parent peptides points to the existence of additional determinants of antimicrobial activity beyond the γ-core. In some cases, the α-core plays this role, as was shown for BhDef12 and BhDef23 α-core peptides of B. hybrida defensins and SmAPα1-21 and SmAPα10-21 of S. marianum defensin [25,38]. In some instances, the residues beyond the γ- and α-core regions were shown to be also important for activity, as exemplified by the radish defensins Rs-AFP1 and Rs-AFP2 [20].

4.1. Residues within γ-Core Sequences Responsible for Antimicrobial Activity

In a number of studies, the residues within the γ-core sequence responsible for activity have been identified. Thus, in the hexapeptide RGFRRR of the MtDef4 γ-core, the residues Phe37 and Arg38 were shown to be important for antimicrobial activity. Their substitution for Ala dramatically decreased activity [9]. The significance of an FR pair in the antifungal activity of the MtDef4 γ-core homologs was also shown for the wheat γ-core peptides TkDEFL1-1155-68 and TkDEFL1-3255-68 [53]. Phe is present in a number of other γ-core peptides (Figure S1); however, it remains unclear whether it is vital for their activity. Only in RsAFP2 Phe was shown to be important for the antifungal activity against F. culmorum [20]. However, most residues of the γ-core are not conserved in γ-cores of different AMPs. In the bi-domain MtDef5, His36 and Arg37 in MtDef5A and His93 and Arg94 in MtDef5B were demonstrated to be essential for antifungal activity [29]. In the RsAFP2 γ-core, beyond Phe40, such functional residues are Tyr38, Pro41 and Lys44 [20]; in the OsAFP1 γ-core motif peptide, Leu39 and Arg41 [50]; and in the maize γ-core peptide ES-d, Leu48, Cys49 and Tyr50 [51].

4.2. The Role of Net Charge in Antimicrobial Activity of γ-Core Peptides

Increasing the positive charge of the γ-core peptide usually enhances antimicrobial efficiency, as was clearly demonstrated for PvD1 variants γ31-45PvD1++ and γ33-41PvD1 (Table 5) [31]. A similar enhancement of the antimicrobial potency was observed in the α-core peptide BhDef12M (Table 2) [25].
Negatively charged or neutral peptides are mostly inactive or weakly active (e.g., nsLTP-derived peptides γ53-69SlLTPg2.5, γ56-72SlLTPg2.4, and γ70-86SlLTPg2.8, BhDef22, etc.) [25,46]. The importance of a positive charge for the antimicrobial activity of all γ-core peptides was argued by comparison of three OefDef1.1 variants harboring three or four neighboring Ala (Table 13) [10]. Their activity was similar or even higher than that of the wild-type peptide, although the charge of the γ-core motif in the Ala variants was lower than that of the parent peptide, suggesting that the activity was more dependent on hydrophobicity than on net charge [10].

4.3. The Role of Peptide’s Length and 3D Structure in Antimicrobial Activity

Regarding the length of the γ-core peptides, the results presented show that the longer peptides are usually more active than the shorter peptides, as follows, for example, from the comparison of antifungal activity of 9- and 15-mer γ-core peptides of PvD1 [31]. For Rs-AFP1, linear peptides with a length of 19 or 20 amino acids displayed the highest antifungal activity. Sequences of 16 amino acid residues or less showed lower levels of antifungal activity [22]. However, there exist certain exceptions: for example, the short positively charged peptide MBG07 of five amino acids derived from the C-terminal region of the Rs-AFP2 γ-core and the hexapeptide RGFRRR found in the γ-cores of different defensins [9,22]. Short peptides exhibiting antimicrobial activity are preferable for practical use due to low production costs; however, other peptide characteristics, such as cytotoxicity, stability, bioavailability, etc., should be additionally explored.
The 3D structure has not been solved for any γ-core peptide. We have carried out molecular modeling of the wheat and tomato γ-core peptides [46,53]. Most peptides have a helical region and are amphipathic, with hydrophobic and polar residues located on opposite sides of the helix. Some were predicted to exist in a random coil conformation. Analyzing the predicted 3D structures, we did not find any correlation between the spatial structure of peptides and their antimicrobial activity. The most potent defensin- and snakin-derived peptides display either α-helical or random-coil conformation. However, similar 3D structures were predicted for the least active LTP- and thionin-derived peptides. The characteristic feature that seems important for the antimicrobial activity of short peptides is the charge of the peptide, which is much higher in the peptides with pronounced antimicrobial properties than in the virtually inactive peptides.

4.4. The Role of Cysteine Residues in Activity

The role of cysteine residues in the activity of γ-core peptides remains ambiguous. The γ-core signature GXCX3-9C harbors two cysteine residues, which are highly reactive and prone to oxidation with the formation of inter and intramolecular disulfide bonds. In order to prevent oxidation, in a number of studies, cysteines in the γ-core motif peptides were substituted with alanine or α-aminobutyric acid. The comparison of the activities of cysteine-containing peptides with those carrying α-aminobutyric acid made for Rs-AFP2 peptides showed that the activity varied depending on the peptide, possibly reflecting differences in the mode of action [22]. Short α-aminobutyric acid-containing peptides showed lower potency than cysteine-containing peptides, while a longer peptide, MBG02, was even more active than the cysteine-containing MBG01. Reduced activity in the variants with cysteine substitutions might indicate that peptide multimerization is a necessary step in the mechanism of action. In the studies of wheat γ-core peptides, the activity of the loop peptides with and without the adjacent cysteine residues demonstrated that for most tested pathogens, the peptides with cysteine residues were more active than those without them [53]. However, for some pathogens, the opposite trend was observed.

4.5. The Mode of Action

The data regarding the mode of action of the γ-core motif peptides is fragmentary. Studies of the antimicrobial activity of the MtDef4 and MtDef5A γ-core peptides towards filamentous fungi showed that they suppressed spore germination, germ tube elongation, and mycelial growth in P. medicaginis and F. solani without causing morphological changes of spores or hyphae [23]. In N. crassa, the ubiquitous RGFRRR peptide derived from the γ-core of MtDef4 selectively inhibited cell fusion [26]. It was also necessary for MtDef4 internalization into the cells of F. graminearum [28]. It was shown that this peptide interacts with high affinity with phosphatidic acid, and this interaction mediates the transport of MtDef4 into the fungal cell walls. MtDef5A γ-core peptide did not act directly on the bacterial OM and possibly had an intracellular target [27].
Pathogen growth inhibition by γ-core peptides starts with membrane permeabilization [9,38,43,46,53]. Subsequent events were investigated only for a limited number of peptides. The fungicidal effect on C. buinensis cells of the γ-core peptide γ33-41PvD1++ occurred due to programmed cell death via an apoptotic pathway involving induction of oxidative stress and dysfunction of mitochondria and activation of metacaspases [31]. The γ-core peptide DD from VuDef1 acted similarly on the parasite L. amazonensis [32]. Studies of the mode of action of the α-core and γ-core peptides derived from the DefSm2-D defensin point to their distinct modes of action [38]. Studies of the mode of action of the γ-core peptide BcDef1 on the bacterial human pathogen S. epidermidis showed that it caused membrane and cell wall damage by altering membrane potential and permeability. The peptide also displayed antioxidant activity without causing cytotoxicity to normal mammalian cells. The γ-core peptide Atr-DEF2(G39-C54) affected the composition of OM in E. coli cells and triggered iron deficiency [40]. The mode of action of the γ-core peptides on different fungi is different, as was shown for the ES-d peptide from the defensin ZmES4 [52].
In addition to antimicrobial activity, a regulatory role was shown for the tomato SolyC07g007760 defensin γ-core peptide SolyC. The SolyC peptide down-regulated the level of the proinflammatory cytokines TNF-α and IFN-γ, thus acting as an antimicrobial and anti-inflammatory agent [44].

4.6. Synergism with Antimycotics

An interesting finding regarding γ-core peptides is that they act in synergy with AMPs and potentiate the action of antimycotics. Thus, the γ-core motif peptides 8 and 9 of Rs-AFP2, in combination with the parent peptide, enhanced the activity of Rs-AFP2 more than two-fold [21]. The γ-core peptide HsLin06 of HsAFP1 defensin acted synergistically with caspofungin in preventing C. albicans biofilm formation [48]. The γ-core peptides of the wheat WAMP-2 were shown to enhance the inhibitory effect of tebuconazole, used in agriculture to combat harmful cereal diseases. The type of interactions between the fungicide and the peptide fragment was either synergistic or additive [54,55].

5. Conclusions

The γ-core motif peptides of plant AMPs exhibit inhibitory activity against plant and human bacterial and fungal pathogens that makes them attractive scaffolds for the development of novel anti-infective agents for medicine and agriculture. At least some of them are multifunctional and combine antimicrobial and immunomodulatory functions, thus broadening the spectrum of practical applications. While γ-core motif peptides preserve all the advantages of AMPs: they are natural, broad-spectrum, and effective, their additional benefits include easy structure modification to enhance antimicrobial potency and other physicochemical characteristics and cost-effective production. Besides, an important advantage of γ-core derived peptides is that they act synergistically with antimycotics and fungicides, so combinations of peptides with conventionally used antifungal agents can be suggested as an effective strategy to reduce the doses of aggressive chemicals. However, to be used as next-generation antimicrobials, they should be additionally explored for cytotoxicity, chemical, and physical stability, bioavailability, etc.
We believe that further research into the γ-core motif peptides will satisfy the increased interest in peptides in pharmaceutical science and agriculture.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms24010483/s1.

Author Contributions

T.I.O. and M.P.S. wrote the paper. E.A.I. and T.V.K. prepared all the figures and tables. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Russian Science Foundation, grant number 22-16-00010.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389–395. [Google Scholar] [CrossRef] [PubMed]
  2. Bosch, T.C.G.; Zasloff, M. Antimicrobial Peptides-or how our ancestors learned to control the microbiome. mBio 2021, 12, e0184721. [Google Scholar] [CrossRef] [PubMed]
  3. Lazzaro, B.P.; Zasloff, M.; Rolff, J. Antimicrobial peptides: Application informed by evolution. Science 2020, 368, eaau5480. [Google Scholar] [CrossRef]
  4. Sarkar, T.; Chetia, M.; Chatterjee, S. Antimicrobial peptides and proteins: From nature’s reservoir to the laboratory and beyond. Front. Chem. 2021, 9, 691532. [Google Scholar] [CrossRef] [PubMed]
  5. Park, S.C.; Park, Y.; Hahm, K.S. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int. J. Mol. Sci. 2011, 12, 5971–5992. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Feurstein, C.; Meyer, V.; Jung, S. Structure–activity predictions from computational mining of protein databases to assist modular design of antimicrobial peptides. Front. Microbiol. 2022, 13, 812903. [Google Scholar] [CrossRef]
  7. Tam, J.P.; Wang, S.; Wong, K.H.; Tan, W.L. Antimicrobial peptides from plants. Pharmaceuticals 2015, 8, 711–757. [Google Scholar] [CrossRef]
  8. Yount, N.Y.; Yeaman, M.R. Multidimensional signatures in antimicrobial peptides. Proc. Natl. Acad. Sci. USA 2004, 101, 7363–7368. [Google Scholar] [CrossRef] [Green Version]
  9. Sagaram, U.S.; Pandurangi, R.; Kaur, J.; Smith, T.J.; Shah, D.M. Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum. PLoS ONE 2011, 6, e18550. [Google Scholar] [CrossRef] [Green Version]
  10. Li, H.; Velivelli, S.L.S.; Shah, D.M. Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens. Mol. Plant. Microbe Interact. 2019, 32, 1649–1664. [Google Scholar] [CrossRef]
  11. Parisi, K.; Shafee, T.M.A.; Quimbar, P.; van der Weerden, N.L.; Bleackley, M.R.; Anderson, M. The evolution, function and mechanisms of action for plant defensins. Semin. Cell Dev. Biol. 2019, 88, 107–118. [Google Scholar] [CrossRef] [PubMed]
  12. Odintsova, T.I.; Slezina, M.P.; Istomina, E.A. Defensins of grasses: A systematic review. Biomolecules 2020, 10, 1029. [Google Scholar] [CrossRef] [PubMed]
  13. Thomma, B.P.; Cammue, B.P.; Thevissen, K. Plant defensins. Planta 2002, 216, 193–202. [Google Scholar] [CrossRef] [PubMed]
  14. Lay, F.T.; Anderson, M.A. Defensins-components of the innate immune system in plants. Curr. Protein Pept. Sci. 2005, 6, 85–101. [Google Scholar] [CrossRef] [PubMed]
  15. Carvalho, A.O.; Gomes, V.M. Plant defensins–prospects for the biological functions and biotechnological properties. Peptides 2009, 30, 1007–1020. [Google Scholar] [CrossRef] [PubMed]
  16. Carvalho, A.O.; Gomes, V.M. Plant defensins and defensin-like peptides - biological activities and biotechnological applications. Curr. Pharm. Des. 2011, 17, 4270–4293. [Google Scholar] [CrossRef] [PubMed]
  17. Terras, F.R.; Schoofs, H.M.; De Bolle, M.F.; Van Leuven, F.; Rees, S.B.; Vanderleyden, J.; Cammue, B.P.; Broekaert, W.F. Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds. J. Biol. Chem. 1992, 267, 15301–15309. [Google Scholar] [CrossRef]
  18. Thevissen, K.; de Mello Tavares, P.; Xu, D.; Blankenship, J.; Vandenbosch, D.; Idkowiak-Baldys, J.; Govaert, G.; Bink, A.; Rozental, S.; de Groot, P.W.; et al. The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans. Mol. Microbiol. 2012, 84, 166–180. [Google Scholar] [CrossRef] [Green Version]
  19. Vriens, K.; Cools, T.L.; Harvey, P.J.; Craik, D.J.; Braem, A.; Vleugels, J.; De Coninck, B.; Cammue, B.P.; Thevissen, K. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms. Peptides 2016, 75, 71–79. [Google Scholar] [CrossRef]
  20. De Samblanx, G.W.; Goderis, I.J.; Thevissen, K.; Raemaekers, R.; Fant, F.; Borremans, F.; Acland, D.P.; Osborn, R.W.; Patel, S.; Broekaert, W.F. Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity. J. Biol. Chem. 1997, 272, 1171–1179. [Google Scholar] [CrossRef]
  21. De Samblanx, G.W.; Fernandez del Carmen, A.; Sijtsma, L.; Plasman, H.H.; Schaaper, W.M.; Posthuma, G.A.; Fant, F.; Meloen, R.H.; Broekaert, W.F.; van Amerongen, A. Antifungal activity of synthetic 15-mer peptides based on the Rs-AFP2 (Raphanus sativus antifungal protein 2) sequence. Pept. Res. 1996, 9, 262–268. [Google Scholar] [PubMed]
  22. Schaaper, W.M.; Posthuma, G.A.; Plasman, H.H.; Sijtsma, L.; Fant, F.; Borremans, F.A.; Thevissen, K.; Broekaert, W.F.; Meloen, R.H.; van Amerongen, A. Synthetic peptides derived from the β2-β3 loop of Raphanus sativus antifungal protein 2 that mimic the active site. J. Pept. Res. 2001, 57, 409–418. [Google Scholar] [CrossRef] [PubMed]
  23. Sathoff, A.E.; Velivelli, S.; Shah, D.M.; Samac, D.A. Plant Defensin peptides have antifungal and antibacterial activity against human and plant pathogens. Phytopathology 2019, 109, 402–408. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Pandey, B.; Tyagi, C.; Prajapati, G.K.; Mishra, A.K.; Hashem, A.; Alqarawi, A.A.; Abd Allah, E.F.; Mohanta, T.K. Analysis of mutations of defensin protein using accelerated molecular dynamics simulations. PLoS ONE 2020, 15, e0241679. [Google Scholar] [CrossRef] [PubMed]
  25. Kaewklom, S.; Euanorasetr, J.; Intra, B.; Panbangred, W.; and Aunpad, R. Antimicrobial activities of novel peptides derived from defensin genes of Brassica hybrid cv Pule. Int. J. Pept. Res. Ther. 2016, 22, 93–100. [Google Scholar] [CrossRef]
  26. Muñoz, A.; Chu, M.; Marris, P.I.; Sagaram, U.S.; Kaur, J.; Shah, D.M.; Read, N.D. Specific domains of plant defensins differentially disrupt colony initiation, cell fusion and calcium homeostasis in Neurospora crassa. Mol. Microbiol. 2014, 92, 1357–1374. [Google Scholar] [CrossRef]
  27. Sathoff, A.E.; Lewenza, S.; Samac, D.A. Plant defensin antibacterial mode of action against Pseudomonas species. BMC Microbiol. 2020, 20, 173. [Google Scholar] [CrossRef]
  28. Sagaram, U.S.; El-Mounadi, K.; Buchko, G.W.; Berg, H.R.; Kaur, J.; Pandurangi, R.S.; Smith, T.J.; Shah, D.M. Structural and functional studies of a phosphatidic acid-binding antifungal plant defensin MtDef4: Identification of an RGFRRR motif governing fungal cell entry. PLoS ONE 2013, 8, e82485. [Google Scholar] [CrossRef] [Green Version]
  29. Islam, K.T.; Velivelli, S.L.S.; Berg, R.H.; Oakley, B.; Shah, D.M. A novel bi-domain plant defensin MtDef5 with potent broad-spectrum antifungal activity binds to multiple phospholipids and forms oligomers. Sci. Rep. 2017, 7, 16157. [Google Scholar] [CrossRef]
  30. Velivelli, S.L.S.; Islam, K.T.; Hobson, E.; Shah, D.M. Modes of action of a bi-domain plant defensin MtDef5 against a bacterial pathogen Xanthomonas campestris. Front. Microbiol. 2018, 9, 934. [Google Scholar] [CrossRef]
  31. Mello, É.O.; Taveira, G.B.; Carvalho, A.O.; Gomes, V.M. Improved smallest peptides based on positive charge increase of the γ-core motif from PvD1 and their mechanism of action against Candida species. Int. J. Nanomed. 2019, 14, 407–420. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Toledo, E.B.; Lucas, D.R.; Simão, T.L.B.V.; Calixto, S.D.; Lassounskaia, E.; Muzitano, M.F.; Damica, F.Z.; Gomes, V.M.; de Oliveira Carvalho, A. Design of improved synthetic antifungal peptides with targeted variations in charge, hydrophobicity and chirality based on a correlation study between biological activity and primary structure of plant defensin γ-cores. Amino Acids 2021, 53, 219–237. [Google Scholar] [CrossRef] [PubMed]
  33. Carvalho, A.O.; Machado, O.L.T.; Da Cunha, M.; Santos, I.S.; Gomes, V.M. Antimicrobial peptides and immunolocalization of a LTP in Vigna unguiculata seeds. Plant Physiol. Biochem. 2001, 39, 137–146. [Google Scholar] [CrossRef]
  34. Souza, G.S.; de Carvalho, L.P.; de Melo, E.J.T.; Gomes, V.M.; Carvalho, A.O. The toxic effect of Vu-Defr, a defensin from Vigna unguiculata seeds, on Leishmania amazonensis is associated with reactive oxygen species production, mitochondrial dysfunction, and plasma membrane perturbation. Can. J. Microbiol. 2018, 64, 455–464. [Google Scholar] [CrossRef] [Green Version]
  35. Dos Santos, I.S.; Carvalho, A.O.; de Souza-Filho, G.A.; do Nascimento, V.V.; Machado, O.L.; Gomes, V.M. Purification of a defensin isolated from Vigna unguiculata seeds, its functional expression in Escherichia coli, and assessment of its insect α-amylase inhibitory activity. Protein Expr. Purif. 2010, 71, 8–15. [Google Scholar] [CrossRef]
  36. Bozelli, J.C., Jr.; Yune, J.; Dang, X.; Narayana, J.L.; Wang, G.; Epand, R.M. Membrane activity of two short Trp-rich amphipathic peptides. Biochim. Biophys. Acta Biomembr. 2020, 1862, 183280. [Google Scholar] [CrossRef]
  37. Souza, G.S.; de Carvalho, L.P.; de Melo, E.J.T.; da Silva, F.C.V.; Machado, O.L.T.; Gomes, V.M.; Carvalho, A.O. A synthetic peptide derived of the β2-β3 loop of the plant defensin from Vigna unguiculata seeds induces Leishmania amazonensis apoptosis-like cell death. Amino Acids 2019, 51, 1633–1648. [Google Scholar] [CrossRef]
  38. Fernández, A.; Colombo, M.L.; Curto, L.M.; Gómez, G.E.; Delfino, J.M.; Guzmán, F.; Bakás, L.; Malbrán, I.; Vairo-Cavalli, S.E. Peptides derived from the α-core and γ-core regions of a putative Silybum marianum flower defensin show antifungal activity against Fusarium graminearum. Front. Microbiol. 2021, 12, 632008. [Google Scholar] [CrossRef]
  39. Osborn, R.W.; De Samblanx, G.W.; Thevissen, K.; Goderis, I.; Torrekens, S.; Van Leuven, F.; Attenborough, S.; Rees, S.B.; Broekaert, W.F. Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae. FEBS Lett. 1995, 368, 257–262. [Google Scholar] [CrossRef] [Green Version]
  40. Moyer, T.B.; Purvis, A.L.; Wommack, A.J.; Hicks, L.M. Proteomic response of Escherichia coli to a membrane lytic and iron chelating truncated Amaranthus tricolor defensin. BMC Microbiol. 2021, 21, 110. [Google Scholar] [CrossRef]
  41. Segura, A.; Moreno, M.; Molina, A.; García-Olmedo, F. Novel defensin subfamily from spinach (Spinacia oleracea). FEBS Lett. 1998, 435, 159–162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Gbala, I.D.; Macharia, R.W.; Bargul, J.L.; Magoma, G. Membrane permeabilization and antimicrobial activity of recombinant defensin-d2 and actifensin against multidrug-resistant Pseudomonas aeruginosa and Candida albicans. Molecules 2022, 27, 4325. [Google Scholar] [CrossRef] [PubMed]
  43. Kaewklom, S.; Wongchai, M.; Petvises, S.; Hanpithakphong, W.; Aunpad, R. Structural and biological features of a novel plant defensin from Brugmansia x candida. PLoS ONE 2018, 13, e0201668. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Rigano, M.M.; Romanelli, A.; Fulgione, A.; Nocerino, N.; D’Agostino, N.; Avitabile, C.; Frusciante, L.; Barone, A.; Capuano, F.; Capparelli, R. A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori. J. Pept. Sci. 2012, 18, 755–762. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Avitabile, C.; Capparelli, R.; Rigano, M.M.; Fulgione, A.; Barone, A.; Pedone, C.; Romanelli, A. Antimicrobial peptides from plants: Stabilization of the γ core of a tomato defensin by intramolecular disulfide bond. J. Pept. Sci. 2013, 19, 240–245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Slezina, M.P.; Istomina, E.A.; Kulakovskaya, E.V.; Abashina, T.N.; Odintsova, T.I. Synthetic oligopeptides mimicking γ-core regions of cysteine-rich peptides of Solanum lycopersicum possess antimicrobial activity against human and plant pathogens. Curr. Issues Mol. Biol. 2021, 43, 1226–1242. [Google Scholar] [CrossRef]
  47. Slezina, M.P.; Istomina, E.A.; Korostyleva, T.V.; Kovtun, A.S.; Kasianov, A.S.; Konopkin, A.A.; Shcherbakova, L.A.; Odintsova, T.I. Molecular insights into the role of cysteine-rich peptides in induced resistance to Fusarium oxysporum infection in tomato based on transcriptome profiling. Int. J. Mol. Sci. 2021, 22, 5741. [Google Scholar] [CrossRef]
  48. Vriens, K.; Cools, T.L.; Harvey, P.J.; Craik, D.J.; Spincemaille, P.; Cassiman, D.; Braem, A.; Vleugels, J.; Nibbering, P.H.; Drijfhout, J.W.; et al. synergistic activity of the plant defensin HsAFP1 and caspofungin against Candida albicans biofilms and planktonic cultures. PLoS ONE 2015, 10, e0132701. [Google Scholar] [CrossRef] [Green Version]
  49. Sagehashi, Y.; Takaku, H.; Yatou, O.J. Partial peptides from rice defensin OsAFP1 exhibited antifungal activity against the rice blast pathogen Pyricularia oryzae. J. Pestic. Sci. 2017, 42, 172–175. [Google Scholar] [CrossRef] [Green Version]
  50. Ochiai, A.; Ogawa, K.; Fukuda, M.; Ohori, M.; Kanaoka, T.; Tanaka, T.; Taniguchi, M.; Sagehashi, Y. Rice defensin OsAFP1 is a new drug candidate against human pathogenic fungi. Sci. Rep. 2018, 8, 11434. [Google Scholar] [CrossRef]
  51. Cordts, S.; Bantin, J.; Wittich, P.E.; Kranz, E.; Lörz, H.; Dresselhaus, T. ZmES genes encode peptides with structural homology to defensins and are specifically expressed in the female gametophyte of maize. Plant J. 2001, 25, 103–114. [Google Scholar] [CrossRef]
  52. Woriedh, M.; Merkl, R.; Dresselhaus, T. Maize EMBRYO SAC family peptides interact differentially with pollen tubes and fungal cells. J. Exp. Bot. 2015, 66, 5205–5216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Slezina, M.P.; Istomina, E.A.; Kulakovskaya, E.V.; Korostyleva, T.V.; Odintsova, T.I. The γ-core motif peptides of AMPs from grasses display inhibitory activity against human and plant pathogens. Int. J. Mol. Sci. 2022, 23, 8383. [Google Scholar] [CrossRef] [PubMed]
  54. Odintsova, T.; Shcherbakova, L.; Slezina, M.; Pasechnik, T.; Kartabaeva, B.; Istomina, E.; Dzhavakhiya, V. Hevein-like antimicrobial peptides WAMPs: Structure–function relationship in antifungal activity and sensitization of plant pathogenic fungi to tebuconazole by WAMP-2-derived peptides. Int. J. Mol. Sci. 2020, 21, 7912. [Google Scholar] [CrossRef] [PubMed]
  55. Shcherbakova, L.; Odintsova, T.; Pasechnik, T.; Arslanova, L.; Smetanina, T.; Kartashov, M.; Slezina, M.; Dzhavakhiya, V. Fragments of a wheat hevein-like antimicrobial peptide augment the inhibitory effect of a triazole fungicide on Fusarium oxysporum and Alternaria solani spore germination. Antibiotics 2020, 9, 870. [Google Scholar] [CrossRef]
Figure 1. Solution structure of plant defensins: (A) MtDEF4 (PDB: 2LR3); (B) PvD1 (PDB: 6VPN); (C) HsAFP1 (PDB: 2N2Q). The γ-core motif is colored red. The α-core motif is colored yellow. The N- and C-termini are indicated by N and C, respectively.
Figure 1. Solution structure of plant defensins: (A) MtDEF4 (PDB: 2LR3); (B) PvD1 (PDB: 6VPN); (C) HsAFP1 (PDB: 2N2Q). The γ-core motif is colored red. The α-core motif is colored yellow. The N- and C-termini are indicated by N and C, respectively.
Ijms 24 00483 g001
Table 1. Rs-AFP2 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are in green. B—α-aminobutyric acid, c—D-cysteine. The α-core is underlined with a dotted line, and the γ-core is with a solid line. Note: nd—not determined, *—both figures are given in the original article [20].
Table 1. Rs-AFP2 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are in green. B—α-aminobutyric acid, c—D-cysteine. The α-core is underlined with a dotted line, and the γ-core is with a solid line. Note: nd—not determined, *—both figures are given in the original article [20].
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
Rs-AFP2    QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+6
Inhibited the growth of Fusarium culmorum with MIC = 3 µg/mL (IC50 = 2.9 (2.1) * µg/mL in a low ionic strength medium SMF− and IC50 = 8.1 (4.6)* µg/mL in the same medium with salts SMF+); Alternaria brassicola with MIC = 3 µg/mL (IC50 = 3.2 µg/mL in a low ionic strength medium SMF− and IC50 > 50 µg/mL in the same medium with salts SMF+); Ascochyta pisi with MIC = 6 µg/mL (IC50 = 1.9 µg/mL in a low ionic strength medium SMF− and IC50 > 50 µg/mL in the same medium with salts SMF+); Botrytis cinerea with MIC = 12 µg/mL (IC50 = 1.8 µg/mL in a low ionic strength medium SMF− and IC50 > 50 µg/mL in the same medium with salts SMF+); Verticillium dahliae with MIC = 3 µg/mL (IC50 = 1 µg/mL in a low ionic strength medium SMF− and IC50 = 11 µg/mL in the same medium with salts SMF+). No activity at 400 µg/mL against bacterial species Aeromonas hydrophila ssp. proteoytica, Pseudomonas fluorescens, Escherichia coli, Bacillus cereus, B. subtilis, Staphylococcus aureus. Inhibited the growth of Nectria hematococca with IC50 = 2 µg/mL in a low ionic strength medium SMF− and IC50 = 48 µg/mL in the same medium with salts SMF+ against; Inhibited the growth of Phoma betae with IC50 = 0.9 µg/mL in a low ionic strength medium SMF− and IC50 = 14 µg/mL in the same medium with salts SMF+ against; Inhibited the growth of F. culmorum with IC50 = 5 µg/mL/.[20,21,22]
Peptide 1     QKLCQRPSGTWSGVC+2
Inhibited the growth of F. culmorum and A. brassicola with MIC = 250 µg/mL; V. dahliae with MIC = 250 µg/mL; A. pisi and B. cinerea with MIC > 500 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
Peptide 2       QRPSGTWSGVCGNNN+1
Inhibited the growth of F. culmorum, A. brassicola, A. pisi, B. cinerea, V. dahliae with MIC > 500 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
Peptide 3         GTWSGVCGNNNACKN+1
Inhibited the growth of F. culmorum and A. brassicola with MIC = 250 µg/mL; V. dahliae with MIC = 250 µg/mL. No activity at 500 µg/mL against A. pisi and B. cinerea. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens.[21]
Peptide 4           GVCGNNNACKNQCIR+2
Inhibited the growth of F. culmorum with MIC = 250−500 µg/mL; A. brassicola with MIC = 500 µg/mL; B. cinerea with MIC = 250 µg/mL; V. dahliae with MIC = 125 µg/mL. No activity at 500 µg/mL against A. pisi. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
Peptide 5             NNNACKNQCIRLEKA+2
Inhibited the growth of F. culmorum with MIC = 250 µg/mL; A. brassicola with MIC = 125 µg/mL; A. pisi with MIC = 500 µg/mL; B. cinerea with MIC = 500 µg/mL; V. dahliae with MIC = 250 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, E. coli, B. cereus, S. aureus; Inhibited the growth of P. fluorescens, B. subtilis with MIC = 400 µg/mL.[21]
Peptide 6               CKNQCIRLEKARHGS+3
Inhibited the growth of F. culmorum with MIC = 45 µg/mL; A. brassicola with MIC = 60 µg/mL; A. pisi with MIC = 125 µg/mL; B. cinerea with MIC = 250 µg/mL; V. dahliae with MIC = 30 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, E. coli, B. cereus, S. aureus; Inhibited the growth of P. fluorescens, B. subtilis with MIC = 100 µg/mL.[21]
Peptide 7                 CIRLEKARHGSCNYV+2
Inhibited the growth of F. culmorum with MIC = 60 µg/mL; A. brassicola with MIC = 60 µg/mL; A. pisi with MIC = 250 µg/mL; B. cinerea with MIC = 250 µg/mL; V. dahlia with MIC = 30 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
Peptide 8                   EKARHGSCNYVFPAH+1
Inhibited the growth of F. culmorum with MIC = 45 µg/mL; A. brassicola with MIC = 30 µg/mL; A. pisi with MIC = 125 µg/mL; B. cinerea with MIC = 250 µg/mL; V. dahliae MIC = 30 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
Peptide 9                     HGSCNYVFPAHKCIC+1
Inhibited the growth of F. culmorum with MIC = 30 µg/mL; A. brassicola with MIC = 60 µg/mL; A. pisi with MIC = 250 µg/mL; B. cinerea with MIC = 250 µg/mL; V. dahliae MIC = 30 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
Peptide 10                       NYVFPAHKCICYFPC+1
Inhibited the growth of F. culmorum and V. dahliae with MIC = 500 µg/mL; A. brassicola, A. pisi and B. cinerea with MIC > 500 µg/mL. No activity at 400 µg/mL against bacterial species A. hydrophila ssp. proteoytica, P. fluorescens, E. coli, B. cereus, B. subtilis, S. aureus.[21]
C36-C45                       CNYVFPAHKC+1
Inhibited the growth of F. culmorum with MIC = 150 µg/mL.[21]
C36-C45(Y38A)                       CNAVFPAHKC+1
Inhibited the growth of F. culmorum with MIC > 400 µg/mL.[21]
Rs-AFP2 (γ-core)                      GSCNYVFPAHKCICYFP+1
IC50 = 5.3 μM against Fusarium tricinctum. No activity at 30 μg/mL against Phoma medicaginis STC and WS-2 strains, F. oxysporum f. sp. medicaginis 7F-3 and 31F-3 strains, Colletotrichum trifolli FG-1 and WS-5 strains, Aphanomyces euteiches, F. redolens, F. incarnatum, F.solani; Inhibited the growth of E. coli, Pseudomonas syringae pv. syringae, Sinorhizobium meliloti.[23]
Rs-AFP2(Q5M)   QKLCMRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+6
IC50 = 4.1 µg/mL in a low ionic strength medium SMF− and IC50 = 5.4 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(T10G)   QKLCQRPSGGWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+6
IC50 = 11 µg/mL in a low ionic strength medium SMF− and IC50 > 100 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(G16M)   QKLCQRPSGTWSGVCMNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+6
IC50 = 2.2 µg/mL in a low ionic strength medium SMF− and IC50 = 5.0 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(A31W)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKWRHGSCNYVFPAHKCICYFPC+6
IC50 = 30 µg/mL in a low ionic strength medium SMF− and IC50 > 100 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(Y38G)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNGVFPAHKCICYFPC+6
IC50 = 42 µg/mL in a low ionic strength medium SMF− and IC50 > 200 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(F40M)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVMPAHKCICYFPC+6
IC50 = 16 µg/mL in a low ionic strength medium SMF− and IC50 = 54 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(P41∆)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFAHKCICYFPC+6
IC50 = 100 µg/mL in a low ionic strength medium SMF− and IC50 > 200 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(K44Q)   QKLCQRPSGWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHQCICYFPC+5
IC50 = 3.6 µg/mL in a low ionic strength medium SMF− and IC50 = 36 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(Y48I)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICIFPC+6
IC50 = 9.3 µg/mL in a low ionic strength medium SMF− and IC50 = 11 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(P7R)   QKLCQRRSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+7
IC50 = 6.8 µg/mL in a low ionic strength medium SMF− and IC50 = 8.8 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(G9R)   QKLCQRPSRTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+7
IC50 = 3 µg/mL in a low ionic strength medium SMF− and IC50 = 3.3 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(S12R)   QKLCQRPSGTWRGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC+7
IC50 = 3.5 µg/mL in a low ionic strength medium SMF− and IC50 = 20 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(I26R)   QKLCQRPSGTWSGVCGNNNACKNQCRRLEKARHGSCNYVFPAHKCICYFPC+7
IC50 = 7.2 µg/mL in a low ionic strength medium SMF− and IC50 = 9.6 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(L28R)   QKLCQRPSGTWSGVCGNNNACKNQCIRREKARHGSCNYVFPAHKCICYFPC+7
IC50 = 6.4 µg/mL in a low ionic strength medium SMF− and IC50 >100 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(N37R)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCRYVFPAHKCICYFPC+7
IC50 = 2.8 µg/mL in a low ionic strength medium SMF− and IC50 = 7.0 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(V39R)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYRFPAHKCICYFPC+7
IC50 = 4.0 (2.2)* µg/mL in a low ionic strength medium SMF− and IC50 = 3.2 (2.3)* µg/mL in the same medium with salts SMF+ against F. culmorum; IC50 = 2.5 µg/mL in a low ionic strength medium SMF− and IC50 = 50 µg/mL in the same medium with salts SMF+ against A. brassicicola; IC50 = 2.0 µg/mL in a low ionic strength medium SMF− and IC50 > 50 µg/mL in the same medium with salts SMF+ against A. pisi; IC50 = 1.6 µg/mL in a low ionic strength medium SMF− and IC50 > 50 µg/mL in the same medium with salts SMF+ against B. cinerea; IC50 = 0.4 µg/mL in a low ionic strength medium SMF− and IC50 = 2.3 µg/mL in the same medium with salts SMF+ against V. dahlia; IC50 = 2.1 µg/mL in a low ionic strength medium SMF− and IC50 = 9 µg/mL in the same medium with salts SMF+ against N. hematococca; IC50 = 1.4 µg/mL in a low ionic strength medium SMF− and IC50 = 40 µg/mL in the same medium with salts SMF+ against P. betae.[20]
Rs-AFP2(A42R)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPRHKCICYFPC+7
IC50 = 4.2 µg/mL in a low ionic strength medium SMF− and IC50 = 18 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(I46R)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCRCYFPC+7
IC50 = 12 µg/mL in a low ionic strength medium SMF− and IC50 > 40 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
Rs-AFP2(F49R)   QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYRPC+7
IC50 = 22 µg/mL in a low ionic strength medium SMF− and IC50 = 23 µg/mL in the same medium with salts SMF+ against F. culmorum.[20]
MBG01                    ARHGSCNYVFPAHKCICYF+2
Inhibited the growth of F. culmorum with IC50 = 33 µg/mL.[22]
MBG02                    ARHGSBNYVFPAHKBIBYFnd
Inhibited the growth of F. culmorum with IC50 = 8 µg/mL.[22]
MBG03                    CRHGSBNYVFPAHKBIBYCnd
Inhibited the growth of F. culmorum with IC50 = 17 µg/mL.[22]
MBG04                    CRHGScNYVFPAHKcIBYCnd
Inhibited the growth of F. culmorum with IC50 = 15 µg/mL.[22]
MAT09                     HGSCNYVFPAHKCIC+1
Inhibited the growth of F. culmorum with IC50 = 41 µg/mL.[22]
MBG05                     HGSBNYVFPAHKBIBnd
Inhibited the growth of F. culmorum with IC50 > 400 µg/mL.[22]
MBG06                    ARHGSC+1
Inhibited the growth of F. culmorum with IC50 = 159 µg/mL.[22]
MBG08                    ARHGSBnd
Inhibited the growth of F. culmorum with IC50 > 400 µg/mL.[22]
MBG07                          HKCICY+1
Inhibited the growth of F. culmorum with IC50 = 16µg/mL.[22]
MBG09                          HKBIBYnd
Inhibited the growth of F. culmorum with IC50 > 400 µg/mL.[22]
MAT02     QRPSGTWSGVCGNNN+1
Inhibited the growth of F. culmorum with IC50 > 400 µg/mL.[22]
overlapping 13- to 15-mer peptides derived from Rs-AFP2(26−49)                 IRLEKARHGSBNYVFPAHKBIBYFnd
15-mer peptide 26−40 had the lowest IC50 = 51 µg/mL against F. culmorum.[22]
overlapping 16- to 20-mer peptides derived from Rs-AFP2(26–49)                 IRLEKARHGSBNYVFPAHKBIBYFnd
Peptide 30–49: IC50 = 5 µg/mL against F. culmorum; Peptide 31–49: IC50 = 6 µg/mL against F. culmorum; Peptide 30–48: IC50 = 10 µg/mL against F. culmorum; Peptide 32–49: IC50 = 9 µg/mL against F. culmorum.[22]
Table 2. BhDef1, BhDef2, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are shown in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 2. BhDef1, BhDef2, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are shown in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
BhDef1--------KLCERGRG--TWSGVCGNNNACKNQCIRLEGAQHGSCNNVFPAHKCICYFPC+4
[25]
BhDef11     KLCERGRG--TWSGVCG+2
BhDef11 showed inhibitory activity against Colletotrichum gloeosporioides DoA c1060 at a concentration of 1.024 mg/mL with inhibition zone around 4 mm, and no activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL; it inhibited the growth of methicillin resistant Staphylococcus aureus (MRSA, ATCC 43300) with MIC99 = 2.23 mg/mL and the growth of Salmonella Typhi (ATCC 13311) with MIC99 = 2.02 mg/mL.[25]
BhDef12             GVCGNNNAC0
No activity against C. gloeosporioides DoA c1060 at a concentration of 0.512 mg/mL and against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL.[25]
BhDef12M             GVCGRRRAC+3
BhDef12M showed inhibitory activity against C. gloeosporioides DoA c1060 at a concentration of 0.52 mM (0.512mg/mL) with inhibition zone around 4 mm; no activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL; inhibited the growth of S. aureus (MRSA) with MIC99 = 0.93 mg/mL; inhibited the growth of Salmonella Typhi with MIC99 = 2.00 mg/mL[25]
BhDef13                     RLEGAQHGSCNNVFPAHKC+1
BhDef13 showed inhibitory activity against C. gloeosporioides DoA c1060 at a concentration of 0.50 mM (1.024 mg/mL) with inhibition zone around 7 mm; no activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL, inhibited the growth of S. aureus (MRSA) with MIC99 = 2.26 mg/mL; inhibited the growth of Salmonella Typhi with MIC99 = 1.71 mg/mL.[25]
BhDef14     KLCERGRG--TWSGVCGNNNACKNQCIR+4
BhDef14 showed inhibitory activity against C. gloeosporioides DoA c1060 at a concentration of 0.36 mM (1.024 mg/mL) with inhibition zone around 3 mm. No activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL, inhibited the growth of S. aureus (MRSA) with MIC99 = 2.40 mg/mL; inhibited the growth of Salmonella Typhi with MIC99 = 1.88 mg/mL.[25]
BhDef2EASALRGGKRCEKRNSSTSFSGVCQYDNACMNQCINLEGAQDGKCNNAVPTPKCICYFPC+2
[25]
BhDef21     KRCEKRNSSTSFSGVCQ+3
No activity against C. gloeosporioides DoA c1060 at a concentration of 0.512 mg/mL; no activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL; inhibited the growth of S. aureus (MRSA) with MIC99 = 2.14 mg/mL; inhibited the growth of Salmonella Typhi with MIC99 = 1.93 mg/mL.[25]
BhDef22                     NLEGAQDGKCNNAVPTPKC0
No activity against C. gloeosporioides DoA c1060 at a concentration of 0.512 mg/mL; no activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL.[25]
BhDef23             GVCQYDNAC−1
BhDef23 showed inhibitory activity against C. gloeosporioides DoA c1060 at a concentration of 1.05 mM (1.024 mg/mL) with inhibition zone around 10 mm; no activity against C. gloeosporioides DoA d0762 and C. capsici DoA c1511 at 1.024 mg/mL; inhibited the growth of S. aureus (MRSA) with MIC99 = 2.93 mg/mL; inhibited the growth of Salmonella Typhi with MIC99 = 1.77 mg/mL.[25]
Table 3. MsDef1, MtDef4, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are shown in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 3. MsDef1, MtDef4, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are shown in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
MsDef1     RTCENLADKYRGPCFS-G-CDTHCTTKENAVSGRCR-DDFRCWCTKRC+3
IC50 = 2−4 μM against F. graminearum; MsDef1 caused 41 ± 5% growth inhibition of F. verticillioides at 24 μM; 90% growth inhibition of Aspergillus flavus at concentrations of 12 to 48 µM; IC50 (germination) > 24.50 µM, IC50(CAT (conidial anastomosis tube) fusion) = 7.62 µM and IC50 (cell death) = 1.62 µM against Neurospora crassa.[9,26]
MsDef1-R38Q     RTCENLADKYRGPCFS-G-CDTHCTTKENAVSGRCR-DDFQCWCTKRC+2
IC50 > 6 μM against F. graminearum.[9]
MsDef1-γ4     RTCENLADKYRGPCFS-G-CDTHCTTKENAVSGRCRGFRRRCWCTKRC+7
IC50 = 1.3−1.5 μM against F. graminearum.[9]
GMA1-C                       GRCR-DDFRCWCTKRC+3
IC50 = 14 μM against F. graminearum; GMA1-C inhibited more than 90% of F. verticillioides growth at 24 µM; 90% growth inhibition of A. flavus at concentrations of 24 µM; IC50 = 12.7 μM against P. medicaginis STC and IC50 = 14.8 μM against P. medicaginis WS-2; No activity at 30 μg/mL against F. oxysporum f. sp. medicaginis 7F-3 and 31F-3 strains, C. trifolli FG-1 and WS-5 strains, A. euteiches, F. solani, F. tricinctum, F. redolens, F. incarnatum; IC50 = 7.9 μM against Xanthomonas alfalfae subsp. alfalfae; IC50 = 8.8 μM against P. syringae pv. syringae; IC50(germination) = 8.54 µM, IC50(CAT fusion) = 6.46 µM and IC50 (cell death) = 24.15 µM against N. crassa.[9,23,26]
GMA1                       GRCR-DDFRC+1
IC50 > 192 μM against F. graminearum; IC50 (germination) > 80 µM, IC50 (CAT fusion) >80 µM and IC50 (cell death) > 80 µM against N. crassa.[9,26]
GMA1-L                         R-DDFR0
IC50 >96 μM against F. graminearum; IC50 (germination) > 80 µM, IC50 (CAT fusion) >80 µM and IC50 (cell death) > 80 µM against N. crassa.[9,26]
ALP1           GPCFS-G-C0
IC50 >48 μM against F. graminearum.[9]
MtDef4     RTCESQSHKFKGPCASDHNCASVCQT-ERFSGGRCRGFRRRCFCTTHC+6
IC50 = 0.75−1 μM against F. graminearum; MtDef4 inhibited more than 90% of F. verticillioides growth at 12 µM; A. flavus growth inhibition of approximately 75% at 48 µM; IC50 = 0.3 μM against P. medicaginis STC and IC50 = 2.6 μM against P. medicaginis WS-2; IC50 = 0.7 μM against against F. oxysporum f. sp. medicaginis 7F-3 and IC50 = 1.9 μM against 31F-3 strain; no activity at 30 μg/mL against A. euteiches, C. trifolli FG-1 and WS-5 strains; IC50 = 0.6 μM against X. alfalfae subsp. alfalfae; IC50 = 0.4 μM against P. syringae pv. syringae; IC50 = 0.1 μM against Clavibacter insidiosus; IC50 (germination) = 0.65 µM, IC50 (CAT fusion) = 0.52 µM and IC50 (cell death) = 0.83 µM against N. crassa.[9,23,26]
GMA4-C                       GRCRGFRRRCFCTTHC+5
IC50 = 3 μM against F. graminearum; GMA4-C inhibited more than 90% of F. verticillioides growth at 3 µM; 90% growth inhibition of A. flavus at concentrations of 6 µM; IC50 = 7.3 μM against P. medicaginis STC and IC50 = 5.3 μM against P. medicaginis WS-2; IC50 = 7.1 μM against F. oxysporum f. sp. medicaginis 7F-3 and IC50 = 6.9 μM against 31F-3 strain. No activity at 30 μg/mL against C. trifolli FG-1 and WS-5 strains, A. euteiches, F. redolens, F. incarnatum; IC50 = 6.0 μM against F. solani; IC50 = 14.7 μM against F. tricinctum; IC50 = 11.4 μM against X. alfalfae subsp. alfalfae; IC50 = 3.4 μM against P. syringae pv. syringae; IC50 = 8.4 μM against Serratia marcescens; IC50 = 2.3 μM against Enterobacter aerogenes; IC50 = 2.7 μM against Pseudomonas aeruginosa; no activity at 30 μg/mL against Enterococcus casseliflavus; IC50 = 1.7-4.2 μM against P. aeruginosa strains; IC50 (germination) = 1.6 µM, IC50 (CAT fusion) = 1.37 µM and IC50 (cell death) = 2.21 µM against N. crassa.[9,23,26,27]
GMA4                       GRCRGFRRRC+5
IC50 = 3 μM against F. graminearum; IC50 (germination) = 2.20 µM, IC50 (CAT fusion) = 1.68 µM and IC50 (cell death) = 2.64 µM against N. crassa.[9,26]
GMA4-L                         RGFRRR+4
IC50 = 4 μM against F. graminearum; IC50 (germination) = 55.38 µM, IC50(CAT fusion) = 4.10 µM and IC50 (cell death) > 80 µM against N. crassa.[9,26]
GMA4-L1                         RGARRR+4
IC50 > 96 μM against F. graminearum.[9]
GMA4-L2                         RGFARR+3
IC50 > 96 μM against F. graminearum.[9]
ALP4            GPCASDHNC−1
IC50 > 48 μM against F. graminearum.[9]
MtDef4RGFRRR/AAAARR      RTCESQSHKFKGPCASDHNCASVCQT-ERFSGGRCAAAARRCFCTTHC+4
Growth inhibition of F. graminearum by less than 10% at 3 µM.[28]
MtDef4RGFRRR/RGAARR      RTCESQSHKFKGPCASDHNCASVCQT-ERFSGGRCRGAARRCFCTTHC+5
More than 90% growth inhibition of F. graminearum at 3 μM.[28]
MtDef4RGFRRR/RGFRAA      RTCESQSHKFKGPCASDHNCASVCQT-ERFSGGRCRGFRAACFCTTHC+4
About 30% growth inhibition of F. graminearum at 3 μM.[28]
Table 4. MtDef5 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The MtDef5 defensin domains, MtDef5A and MtDef5B are connected by a 7-amino acid linker shown in italic. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 4. MtDef5 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The MtDef5 defensin domains, MtDef5A and MtDef5B are connected by a 7-amino acid linker shown in italic. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
MtDef5   KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACHRQGFGFACFCYKKCAPKKVEP
   KLCERRSKTWSGPCLISGNCKRQCINVEHATSGACHRQGIGFACFCKKKC
+16
MtDef5 inhibited the growth of F. graminearum and N. crassa with an IC50 value of 0.25–0.3 µM (MIC of 0.70–0.75 µM). It also inhibited the growth of several other filamentous plant fungal pathogens including F. verticilloides, F. thapsinum, Alternaria brassicicola, Colletotrichum higginsianum, and Botrytis cinerea, C. higginsianum was the least sensitive pathogen among this group of fungal pathogens with an IC50 value of 1.75 µM (MIC of 3.0 µM); MtDef5 inhibited the growth of Xanthomonas campestris with MIC of 12 µM and Clavibacter michiganensis with MIC > 12 µM; IC50 = 1.5 μM against P. medicaginis STC and IC50 = 1.6 μM against P. medicaginis WS-2; IC50 = 0.8 μM against agaisnt F. oxysporum f. sp. medicaginis 7F-3 and IC50 = 1.3 μM against 31F-3 strain; no activity at 30 μg/mL against C. trifolli FG-1 and WS-5 strains, A. euteiches; IC50 = 0.1 μM against P. syringae pv. syringae; no activity at 30 μg/mL against X. alfalfae subsp. alfalfae and Clavibacter insidiosus.[23,29,30]
MtDef5A   KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACHRQGFGFACFCYKKC+7
MtDef5A inhibited the growth of F. graminearum with an IC50 value of 0.75–1.0 µM (MIC of 1.5-3.0 µM); inhibited the growth of X. campestris with MIC of 12 µM and C. michiganensis with MIC > 12 µM.[29,30]
MtDef5B   KLCERRSKTWSGPCLISGNCKRQCINVEHATSGACHRQGIGFACFCKKKC+8
MtDef5B inhibited the growth of F. graminearum with an IC50 value of 0.5–0.75 µM (MIC of 1.0–1.5 µM); inhibited the growth of X. campestris with MIC of 6 µM and C. michiganensis with MIC > 12 µM.[29,30]
MtDef5H36A, R37A/H93A, R94A (MtDef5_V1)   KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACAAQGFGFACFCYKKCAPKKVEP
   KLCERRSKTWSGPCLISGNCKRQCINVEHATSGACAAQGIGFACFCKKKC
+14
MtDef5_V1 almost completely lost its antifungal activity against F. graminearum; inhibited the growth of X. campestris and C. michiganensis with MIC > 12 µM.[29,30]
MtDef5Q38A, G39A/Q95A, G96A (MtDef5_V2)   KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACHRAAFGFACFCYKKCAPKKVEP
   KLCERRSKTWSGPCLISGNCKRQCINVEHATSGACHRAAIGFACFCKKKC
+16
MtDef5_V2 showed 2-fold reduction in its antifungal activity against F. graminearum relative to that of MtDef5.[29]
MtDef5F40A, G41A/I97A, G98A (MtDef5_V3)   KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACHRQGAAFACFCYKKCAPKKVEP
   KLCERRSKTWSGPCLISGNCKRQCINVEHATSGACHRQGAAFACFCKKKC
+16
MtDef5_V3 retained MtDef5 antifungal activity against F. graminearum.[29]
MtDef5F42A/F99A (MtDef5_V4)   KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACHRQGFGAACFCYKKCAPKKVEP
   KLCERRSKTWSGPCLISGNCKRQCINVEHATSGACHRQGIGAACFCKKKC
+16
MtDef5_V4 retained MtDef5 antifungal activity against F. graminearum.[29]
MtDef5A (γ-core)                     GACHRQGFGFACFCYKKC+3
IC50 = 19.5 μM against P. medicaginis STC and IC50 = 8.5 μM against P. medicaginis WS-2; IC50 = 4.1 μM against F. solani; no activity at 30 μg/mL agaisnt F. oxysporum f. sp. medicaginis 7F-3 and 31F-3 strains, C. trifolli FG-1 and WS-5 strains, A. euteiches, F. tricinctum, F. redolens, F. incarnatum; IC50 = 4.5 μM against P. syringae pv. syringae; no activity at 30 μg/mL against X. alfalfae subsp. alfalfae; IC50 = 6.0 μM against S. marcescens; IC50 = 2.8 μM against E. aerogenes; IC50 = 11.8 μM against P. aeruginosa; no activity at 30 μg/mL against Enterococcus casseliflavus; IC50 = 8.5–14.6 μM against P. aeruginosa strains.[23,27]
Table 5. PvD1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 5. PvD1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
PvD1     KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC+2
Inhibited the growth of the yeasts, C. albicans, C. parapsilosis, C. tropicalis, C. guilliermondii, Kluyveromyces marxiannus and Saccharomyces cerevisiae and phytopathogenic fungi including F. oxysporum, F. solani, F. lateritium and Rizoctonia solani.[31]
γ31-45PvD1                       RSGRARDDFRAWATK+3
40% growth inhibition of C. albicans at 293.6 μM; 100% growth inhibition of C. buinensis at 293.6 μM.[31]
γ31-45PvD1++                       RSGRARRRFRAWATK+7
100% growth inhibition of C. albicans at 73.4 μM; 100% growth inhibition of C. buinensis at 18.35 μM.[31]
γ33-41PvD1                        GRARDDFRA+1
No activity at 293.6 μM against C. albicans; 17% growth inhibition of C. buinensis at 293.6 μM.[31]
γ33-41PvD1++                        GRARRRFRA+5
63% growth inhibition of C. albicans at 293.6 μM; 100% growth inhibition of C. buinensis at 36.7 μM.[31]
Table 6. VuDef1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 6. VuDef1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
VuDef1     KTCENLADTYRGPCFTTGSCDDHCKNKEHLLSGRCRDDVRCWCTRNC+1
51% growth inhibition of Leishmania amazonensis at 18.5 μM.[32]
A36,42,44γ32-46VuDef (DD)                      LSGRARDDVRAWATR+2
41% growth inhibition of L. amazonensis at 18.5 μM; no activity at 18.5 μM against C. albicans, C. buinensis, C. tropicalis, Saccharomices cerevisiae, C. parapsilosis and C. pelliculosa.[32]
A36,42,44R37,38γ32-46VuDef (RR)                      LSGRARRRVRAWATR+6
47.5, 100 and 72.1% growth inhibition of C. albicans, C. buinensis, and C. tropicalis, respectively, at 18.5 μM; for C. tropicalis, MIC100 and LD100 = 27.5 μM; no activity at 18.5 μM against S. cerevisiae, C. parapsilosis and C. pelliculosa.[32]
D-A36,42,44R37,38γ32-46VuDef (D-RR)                      LSGRARRRVRAWATR+6
84.9, 99.7, and 100% growth inhibition of C. albicans, C. buinensis, and C. tropicalis, respectively, at 18.5 μM; for C. albicans, MIC100 = 23 μM and LD100 = 36.5 μM; for C. tropicalis, MIC100 = 14 μM and LD100 = 23 μM; no activity at 18.5 μM against S. cerevisiae, C. parapsilosis and C. pelliculosa.[32]
A42,44R37,38W36,39γ32-46VuDef (WR)                      LSGRWRRRWRAWATR+6
26.1, 96.2, 98.5, and 58.2% growth inhibition of S. cerevisiae, C. albicans, C. buinensis, and C. tropicalis, respectively, at 18.5 μM; for C. albicans, MIC100 = 18.5 μM and LD100 = 27.5 μM; no activity at 18.5 μM against C. parapsilosis and C. pelliculosa.[32]
Table 7. DefSm2-D, Atr-DEF2, So-D2, BcDef, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 7. DefSm2-D, Atr-DEF2, So-D2, BcDef, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
DefSm2-D-----KLCEKPSKTWFGNCGNPRHCGDQCKSWEGAVHGACHVRNGKHMCFCYFNCPQAE+3
[38]
SmAPγ27-44                  WEGAVHGACHVRNGKHMC+1
Inhibited the growth of F. graminearum with MIC = 20 µM.[38]
SmAPγ29-35                   GAVHGAC0
No activity at 100 μM against F. graminearum.[38]
SmAPα1-21     KLCEKPSKTWFGNCGNPRHCG+3
Inhibited the growth of F. graminearum with MIC = 32 µM.[38]
SmAPα10-21           WFGNCGNPRHCG+1
Inhibited the growth of F. graminearum with MIC = 70 µM.[38]
Atr-DEF2-----RICESASYRFKGICVSRTNCANVCKT-EGFPGGRCRG--FRRRCFCYKHCA+9
[40]
Atr-DEF2(G39-C54)                     GRCRG--FRRRCFCYKHC+6
IC50 = 9 μM against E. coli; IC50 = 68 μM against Klebsiella pneumoniae.[40]
So-D2GIFSSRKCKTPSKTFKGICTRDSNCDTSCR-YEGYPAGDCKG--IRRRCMCSKPC+8
EC50 (effective concentration for 50% inhibition) = 1 μM against C. michiganensis; EC50 = 2 μM against Ralstonia solanacearum; EC50 = 0.2 μM against F. culmorum; EC50 = 11 μM against F. solani; MIC = 7.5 μg/mL against P. aeruginosa ATCC 27853; MIC = 7.5 μg/mL against C. albicans ATCC 64124. It also inhibited E. coli ATCC 25922 (MIC = 30 μg/mL) and K. pneumoniae ATCC 700603 (MIC = 30 μg/mL).[41,42]
So-D2 (γ-core)                     GDCKG--IRRRCMCSKPL+4
IC50 = 6.4 μM against P. medicaginis STC and IC50 = 6.1 μM against P. medicaginis WS-2; IC50 = 33.1 μM against F. oxysporum f. sp. medicaginis 7F-3; IC50 = 13.8 μM against F. solani; No activity at 30 μg/mL against F. oxysporum f. sp. medicaginis 31F-3, F. redolens, F. incarnatum, F. tricinctum, C. trifolli FG-1 and WS-5 strains, A. euteiches; IC50 = 25.9 μM against P. syringae pv. syringae; IC50 = 19.3 μM against X. alfalfae subsp. alfalfae; No activity at 30 μg/mL against C. insidiosus[23]
BcDef-----RHCESQSQRFKGTCLSEKNCASVCE-TEGFSGGDCRG--LRRRCFCTRPC+4
[43]
BcDef1                     FSGGDCRG--LRRRCFCTR+4
Inhibited the growth of Gram-negative E. coli ATCC25922 with MIC > 251.21 µM; E. coli O157 with MIC = 229.09 µM; P. aeruginosa with MIC > 251.21 µM; Vibrio cholerae with MIC = 125.61 µM; Shigella sonnei with MIC = 125.61 µM; Staphylococcus typhimurium with MIC = 31.40 µM; Gram-positive Enterococcus faecalis with MIC = 251.21 µM; B. cereus with MIC = 251.21 µM; Staphylococcus aureus ATCC25923 and MRSA with MIC >251.21 µM; Staphylococcus epidermidis with MIC = 15.70 µM.[43]
Table 8. Solyc07g007760, SlDEFL2, SlDEFL4, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 8. Solyc07g007760, SlDEFL2, SlDEFL4, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
Solyc07g007760     RHCESLSHRFKGPCVSDKNCASVCETERFSGGNCRGFRRRCFCTKPC+6
[44]
SolyC                      FSGGNCRGFRRRCFCTK+5
Inhibited the growth of Gram-negative E. coli ATCC25922 and Salmonella enterica serovar Parathyphi with MIC = 15 µg/mL; Helicobacter pylori with MIC = 10−15 µg/mL; inhibited the growth of Gram-positive Staphylococcus aureus A170, S. epidermidis and Listeria monocytogenes with MIC = 40 µg/mL; 15% and 13% growth inhibition of Lactobacillum plantarum and L. paracasei at 50 μg/mL, respectively.[44]
SolyC-t                        GNCRGFRRRCFCTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B and H. pylori with MIC = 15 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 50 µg/mL; S. epidermidis and L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC1                      FSGGNCRGFRRRCFSTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B with MIC = 40 µg/mL; H. pylori with MIC = 15 µg/mL; Inhibited the growth of Gram-positive S. aureus with MIC = 50 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC1-t                         GNCRGFRRRCFSTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B with MIC = 80 µg/mL; H. pylori with MIC = 15 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 50 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC2                      FSGGNCRGFRRRSFCTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B and H. pylori with MIC = 15 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 80 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC2-t                         GNCRGFRRRSFCTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B with MIC = 40 µg/mL; H. pylori with MIC = 20 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 80 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL[45]
SolyC1-ox (C6–C13)                      FSGGNCRGFRRRCFSTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B and H. pylori with MIC = 15 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 80 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC1-t-ox (C6–C13)                         GNCRGFRRRCFSTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B and H. pylori with MIC = 15 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 50 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC2-ox (C6–C15)                      FSGGNCRGFRRRSFCTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B with MIC = 10 µg/mL; H. pylori with MIC = 20 µg/mL; inhibited the growth of Gram-positive S. aureus and S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SolyC2-t-ox (C6–C15)                         GNCRGFRRRSFCTK+5
Inhibited the growth of Gram-negative S. enterica serovar Parathyphi B and H. pylori with MIC = 20 µg/mL; inhibited the growth of Gram-positive S. aureus with MIC = 80 µg/mL; S. epidermidis with MIC = 100 µg/mL; L. monocytogenes with MIC = 80 µg/mL.[45]
SlDEFL2     RTCESQSHRFKGPCVSEKNCASVCETEGFSGGDCRGFRRRCFCTRPC+4
[46]
γ58-74SlDEFL2                      FSGGDCRGFRRRCFCTR+4
IC50 = 11.5 μM against Cryptococcus neoformans; IC50 = 19.8 μM against Clavibacter michiganensis; IC50 = 44.8 μM against F. culmorum; IC50 = 165.8 μM against F. oxysporum; 97% growth inhibition of C. albicans at 300 μM; 85% growth inhibition of Pseudomonas savastanoi at 300 μM; 48% growth inhibition of Pectobacterium carotovorum at 300 μM; 31% growth inhibition of Botrytis cinerea at 300 μM; no activity against F. solani, F. verticillioides, Bipolaris sorokiniana at 300 μM.[46]
SlDEFL4     RTCESQSHHFKGNCLSDTNCGSVCRTEGFTGGNCRGFRRRCFCTRNC+5
[46]
γ58-74SlDEFL4                      FTGGNCRGFRRRCFCTR+5
IC50 = 8.1 μM against C. neoformans; IC50 = 21.5 μM against C. michiganensis; IC50 = 42.3 μM against F. culmorum; IC50 = 124.8 μM against F. oxysporum; 97% growth inhibition of C. albicans at 300 μM; 100% growth inhibition of P. savastanoi at 300 μM; 81% growth inhibition of P. carotovorum at 300 μM; 45% growth inhibition of B. cinerea at 300 μM; No activity against F. solani, F. verticillioides, B. sorokiniana at 300 μM.[46]
Table 9. HsAFP1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. B—α-aminobutyric acid. The α-core is underlined with a dotted line, and the γ-core is with a solid line. Note: nd—not determined.
Table 9. HsAFP1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. B—α-aminobutyric acid. The α-core is underlined with a dotted line, and the γ-core is with a solid line. Note: nd—not determined.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
HsAFP1    DGVKLCDVPSGTWSGHCGSSSKCSQQCKDREHFAYGGACHYQFPSVKCFCKRQC+3
IC50 = 0.45 μM against F. culmorum; MIC50 = 18.00 μM against planktonic C. albicans cultures; BIC50 (biofilm formation) = 11.00 μM against C. albicans.[48]
HsLin01    DGVKLBDVPSGTWSGHBGSSSKBSnd
BIC50 > 175 μM against C. albicans.[48]
HsLin02        DVPSGTWSGHBGSSSKBSQQBKDRnd
BIC50 > 175 μM against C. albicans.[48]
HsLin03            WSGHBGSSSKBSQQBKDREHFAYGnd
BIC50 = 96.78 μM against C. albicans.[48]
HsLin04              SSSKBSQQBKDREHFAYGGABHYQnd
BIC50 > 175 μM against C. albicans.[48]
HsLin05                  QQBKDREHFAYGGABHYQFPSVKBnd
BIC50 = 160.00 μM against C. albicans.[48]
Table 10. OsAFP1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 10. OsAFP1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
OsAFP1     RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGLERKCFCKKVC+5
IC50 = 2 μM against C. albicans (MIC = 4 μM); MIC = 4 μM and 16 μM against Saccharomyces cerevisiae By4742 and S288C strains, respectively; MIC > 32 μM against Gram-negative bacteria Porphyromonas gingivalis and E. coli; MIC > 32 μM against Gram-positive bacteria Streptococcus mutans, Staphylococcus aureus, Propionibacterium acnes; IC50 = 0.99 μg/mL against Pyricularia oryzae; IC50 = 1.48 μg/mL against Rhizoctonia solani; IC50 = 3.75 μg/mL against Gibberella fujikuroi; IC50 > 30 μg/mL against bacteria Burkholderia plantari, B. glumae and Acidovorax evenae.[49,50]
OsAFP1 (K35A)     RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECASHGLERKCFCKKVC+4
IC50 = 15 μM against C. albicans.[50]
OsAFP1 (H37A)     RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSAGLERKCFCKKVC+5
IC50 = 17 μM against C. albicans.[50]
OsAFP1 (L39A)     RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGAERKCFCKKVC+5
IC50 > 32 μM against C. albicans.[50]
OsAFP1 (R41A)     RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGLEAKCFCKKVC+4
IC50 > 32 μM against C. albicans.[50]
OsAFP1 (K42A)     RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGLERACFCKKVC+4
IC50 = 20 μM against C. albicans.[50]
Peptide 1     RHCLSQSHRF+2
IC50 = 6 μM against C. albicans; IC50 = 0.41 μg/mL against P. oryzae.[49,50]
Peptide 2         SHRFKGMCVS+2
IC50 = 19 μM against C. albicans; IC50 = 0.87 μg/mL against P. oryzae.[49,50]
Peptide 3             VSSNNCANV0
IC50 > 25 μM against C. albicans; IC50 > 30 μg/mL against P. oryzae.[49,50]
Peptide 4              SNNCANVCRTE0
IC50 > 25 μM against C. albicans; IC50 > 30 μg/mL against P. oryzae.[49,50]
Peptide 5                   RTESFPDGE−2
IC50 > 25 μM against C. albicans; IC50 > 30 μg/mL against P. oryzae.[49,50]
Peptide 6                     FPDGECKSHG−1
IC50 > 25 μM against C. albicans; IC50 > 30 μg/mL against P. oryzae.[49,50]
Peptide 7                         KSHGLERKCF+2
IC50 = 10 μM against C. albicans; IC50 = 0.84 μg/mL against P. oryzae.[49,50]
Peptide 8                            ERKCFCKKVC+3
IC50 = 13 μM against C. albicans; IC50 = 1.42 μg/mL against P. oryzae.[49,50]
Table 11. ZmES1, ZmES4, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The γ-core is underlined with a solid line.
Table 11. ZmES1, ZmES4, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red and substituted amino acids are in green. The γ-core is underlined with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
ZmES1    RDCLTQSTRLPGHLCVRSDYCAIGCRAEGKGYTGGRCLISPIPLDGILCYCVKPCPSNTTT+3
66.7% germination inhibition of F. graminearum at 90 μM; 55.9% germination inhibition of Ustilago maydis at 90 μM.[52]
ZmES4    RDCLTQSTRLPGHLCVRSDYCAIGCRAEGKGYTGGRCLISPITLDGILCYCVKPCTSTTTK+4
67.8% germination inhibition of F. graminearum at 90 μM; 56.4% germination inhibition of U. maydis at 90 μM.[52]
mES4    RDCLTQSTRLPGHLCVRSDYCAIGCRAEGKGYTGGRCQISPITLAVIQCYCVKPCTSTTTK+5
Significant inhibition was not observed.[52]
ES-a    RDCLTQSTRLPGHLCV+1
Significant inhibition was not observed.[52]
ES-b            LCVRSDYCAIGCR+1
Significant inhibition was not observed.[52]
ES-c                   GCRAEGKGYTGGRCL+2
77.1% germination inhibition of F. graminearum at 90 μM; 80.9% germination inhibition of U. maydis at 90 μM.[52]
ES-d                           RCLISPITLDGILCY0
79.3% germination inhibition of F. graminearum at 90 μM; 78.7% germination inhibition of U. maydis at 90 μM.[52]
mES-d1                           RCQISPITLAVIQCY+1
Significant inhibition was not observed.[52]
mES-d2                           RCLAAAATLDGILCY0
Significant inhibition was not observed.[52]
ES-e                                     LCYCVKPCTSTTTK+2
Significant inhibition was not observed.[52]
Table 12. TkDEFL1s and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 12. TkDEFL1s and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
TkDEFL1-11    RICTGKSQHHSFPCISDKSCTKTCLGEHGAKWTAGYCK--ISR-CTCQREC+5
[53]
TkDEFL1-1155-68                       GYCK---ISR-CTCQREC+2
11% germination inhibition C. neoformans at 300 μM; 17% germination inhibition of C. albicans at 300 μM; 11% germination inhibition of P. carotovorum at 300 μM; No activity at 300 μM against F. culmorum, F. oxysporum, F. solani, F. verticillioides, C. michiganensis, P. savastanoi.[53]
TkDEFL1-32    RICTGKSQHHSFPCISDKSCTKTCLGEHGAKWTAGYCK---FRR-CTCQREC+6
[53]
TkDEFL1-3255-68                       GYCK---FRR-CTCQREC+3
IC50 = 42.9 μM against C. neoformans (100% germination inhibition at 80 μM); 92% germination inhibition of C. albicans at 300 μM; IC50 = 38.5 μM against C. michiganensis (76% germination inhibition at 300 μM); IC50 = 97.8 μM against F. culmorum (79% germination inhibition at 150 μM); IC50 = 89.3 μM against F. oxysporum (71% germination inhibition at 300 μM); 39% germination inhibition of P. savastanoi at 300 μM; 56% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. solani, F. verticillioides.[53]
TkDEFL1-12    KICRQRSAGFKGPCLSDKNCAQVCLQER---WGGGNCDG--PFRRCKCIRQC+7
[53]
TkDEFL1-1262-77                       GNCDG--PFRRCKCIRQC+3
IC50 = 37.3 μM against C. neoformans (97% germination inhibition at 100 μM); 5% germination inhibition of C. albicans at 300 μM; IC50 = 69.1 μM against C. michiganensis (89% germination inhibition at 300 μM); 71% germination inhibition of F. culmorum at 300 μM; 62% germination inhibition of F. oxysporum at 300 μM; 45% germination inhibition of F. solani at 300 μM; 6% germination inhibition of P. savastanoi at 300 μM; 30% germination inhibition of P. carotovorum at 300 μM; no activity against F. verticillioides.[53]
TkDEFL1-16    RTCESRSHRFRGPCVRRSNCANVCKTEG-FP--DGKCRG--FRRRCFCTTHCHH+9
[53]
TkDEFL1-1665-82                       GKCRG--FRRRCFCTTHCHH+5
IC50 = 4.4 μM against C. neoformans (100% germination inhibition at 20 μM); IC50 = 14.6 μM against C. albicans (96% germination inhibition at 20 μM); IC50 = 14.6 μM against C. michiganensis (91% germination inhibition at 20 μM); IC50 = 20.7 μM against F. culmorum (82% germination inhibition at 30 μM); IC50 = 12.1 μM against F. oxysporum (81% germination inhibition at 30 μM); IC50 = 52.5 μM against F. solani (74% germination inhibition at 150 μM); IC50 = 48.4 μM against F. verticillioides (59% germination inhibition at 150 μM); IC50 = 56.2 μM against P. savastanoi (100% germination inhibition at 100 μM); IC50 = 70.7 μM against P. carotovorum (100% germination inhibition at 100 μM).[53]
TkDEFL1-20    RTCLSQSHKFKGTCLSNSNCAGVCRTEN-FP--DGECNTHLVERKCYCKRTC+4
[53]
TkDEFL1-2065-82                       GECNTHLVERKCYCKRTC+2
74% germination inhibition of C. neoformans at 300 μM; 14% germination inhibition of C. albicans at 300 μM; 94% germination inhibition of C. michiganensis at 300 μM; 48% germination inhibition of F. culmorum at 300 μM; 53% germination inhibition of F. oxysporum at 300 μM; 31% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. solani, F. verticillioides, P. savastanoi.[53]
TkDEFL1-23    RTCLSQSHKFKGTCLSNSNCAGVCRTEN-FP--DGECNSHRLERKCYCKRTC+5
[53]
TkDEFL1-2365-82                       GECNSHRLERKCYCKRTC+3
IC50 = 39.8 μM against C. neoformans (98% germination inhibition at 100 μM); IC50 = 57.1 μM against C. michiganensis (93% germination inhibition at 300 μM); IC50 = 46 μM against F. culmorum (75% germination inhibition at 75 μM); IC50 = 56.7 μM against F. oxysporum (70% germination inhibition at 150 μM); 28% germination inhibition of P. savastanoi at 300 μM; 29% germination inhibition of P. carotovorum at 100 μM; No activity at 300 μM against C. albicans, F. solani, F. verticillioides.[53]
TkDEFL1-40    RTCLSQSHKFKGTCLSNSNCAGVCRTEN-FP--DGECNSHRLERKCFCKRTC+5
[53]
TkDEFL1-4065-82                       GECNSHRLERKCFCKRTC+3
IC50 = 39.0 μM against C. neoformans (98% germination inhibition at 100 μM); IC50 = 51.6 μM against C. michiganensis (88% germination inhibition at 300 μM); IC50 = 59.3 μM against F. culmorum (78% germination inhibition at 150 μM); IC50 = 49.9 μM against F. oxysporum (78% germination inhibition at 150 μM); 32% germination inhibition of P. savastanoi at 300 μM; 19% germination inhibition of P. carotovorum at 300 μM; No activity at 300 μM against C. albicans, F. solani, F. verticillioides.[53]
TkDEFL1-36    RDCLSQSHKFKGACISSSNCAGVCRTEN-FP--DGECHTHNFARKCFCKRAC+4
[53]
TkDEFL1-3665-82                       GECHTHNFARKCFCKRAC+3
IC50 = 16.8 μM against C. neoformans (100% germination inhibition at 50 μM); 97% germination inhibition of C. albicans at 300 μM; IC50 = 48.6 μM against C. michiganensis (100% germination inhibition at 100 μM); IC50 = 38.3 μM against F. culmorum (80% germination inhibition at 50 μM); IC50 = 52.4 μM against F. oxysporum (80% germination inhibition at 70 μM);45% germination inhibition of F. solani at 300 μM; 55% germination inhibition of F. verticillioides at 180 μM; 54% germination inhibition of P. carotovorum at 300 μM; No activity against P. savastanoi at 300 μM.[53]
TkDEFL4-4   EQSISYKSLDQAHQACPKHGTCAPRGFSYTRGAKCIFYNGECLG+2
[53]
TkDEFL4-446-57               APRGFSYTRGAK+3
40% germination inhibition of C. neoformans at 300 μM; 18% germination inhibition of C. albicans at 300 μM; 19% germination inhibition of F. culmorum at 300 μM; 8% germination inhibition of F. oxysporum at 300 μM; 24% germination inhibition of F. solani at 300 μM; 28% germination inhibition of F. verticillioides at 300 μM; 21% germination inhibition of P. savastanoi at 300 μM; 12% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against C. michiganensis.[53]
TkDEFL4-8-----------GTTHAIPVPTLRGIEDDDVGFAEREE--AAYP-RRRV
LYGDQYISYKGVQASRPACS--GSCAGRGQPYT-GSGCQAIFG-CHGR
+1
[53]
TkDEFL4-882-94              CAGRGQPYT-GSGC+1
8% germination inhibition of C. neoformans at 300 μM; 17% germination inhibition of C. albicans at 300 μM; 14% germination inhibition of C. michiganensis at 300 μM; 10% germination inhibition of F. oxysporum at 300 μM; 15% germination inhibition of F. solani at 300 μM; 26% germination inhibition of F. verticillioides at 300 μM; 19% germination inhibition of P. savastanoi at 300 μM; 42% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. culmorum.[53]
TkDEFL4-883-93               AGRGQPYT-GSG+1
3% germination inhibition of C. neoformans at 300 μM; 26% germination inhibition of C. albicans at 300 μM; 11% germination inhibition of C. michiganensis at 300 μM; 17% germination inhibition of F. oxysporum at 300 μM; 35% germination inhibition of F. solani at 300 μM; 13% germination inhibition of F. verticillioides at 300 μM; 5% germination inhibition of P. savastanoi at 300 μM; 12% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. culmorum.[53]
TkDEFL4-37AALARIDAAAAVMPTSSATWMKLEDGVAPELLGSTA---VDLEGHRRV
LAS-TSITASSLNPNKAACTRT--CPARGRPYT-GRACLRRYQ-CRQGQ
+6
[53]
TkDEFL4-3790-102              CPARGRPYT-GRAC+3
100% germination inhibition of C. neoformans at 300 μM; 38% germination inhibition of C. albicans at 300 μM; 24% germination inhibition of F. culmorum at 300 μM; 31% germination inhibition of F. oxysporum at 300 μM; 34% germination inhibition of F. verticillioides at 150 μM; 38% germination inhibition of P. savastanoi at 300 μM; 36% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against C. michiganensis and F. solani.[53]
TkDEFL4-3791-101               ARGRPYT-GRA+3
10% germination inhibition of C. neoformans at 300 μM; 29% germination inhibition of C. albicans at 300 μM; 29% germination inhibition of F. culmorum at 300 μM; 18% germination inhibition of F. oxysporum at 300 μM; 25% germination inhibition of F. verticillioides at 300 μM; 14% germination inhibition of P. savastanoi at 300 μM; no activity at 300 μM against C. michiganensis, F. solani and P. carotovorum.[53]
TkDEFL4-20DISAGFAASGAAYSIDAAVRQLMSPSSMKLEDGVDPEFSVDLEVHRRV
LAG---ISPGALSRNRPACP--GACPAPGGSYT-NRGCQKKYQ-CRG
+2
[53]
TkDEFL4-2086-110              ACP--GACPAPGGSYT-NRGCQKKYQ-CR+4
95% germination inhibition of C. neoformans at 300 μM; 11% germination inhibition of C. albicans at 300 μM; 91% germination inhibition of C. michiganensis at 300 μM; 60% germination inhibition of F. culmorum at 150 μM; 54% germination inhibition of F. oxysporum at 150 μM; 14% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. solani, F. verticillioides and P. savastanoi.[53]
TkDEFL4-2092-102                   PAPGGSYT-NRG+1
15% germination inhibition of C. neoformans at 300 μM; 16% germination inhibition of C. albicans at 300 μM; 9% germination inhibition of C. michiganensis at 300 μM; 6% germination inhibition of F. oxysporum at 300 μM; 14% germination inhibition of F. solani at 300 μM; 5% germination inhibition of F. verticillioides at 300 μM; no activity at 300 μM against F. culmorum, P. savastanoi and P. carotovorum.[53]
HvDEFL4-1----------------------------AAFAGGTASIDMAAAVHRRI
LAD-PGLGSGVYNANNAACGSQ--CAGHGKRYT-GRGCDSFYG-CRSKPP
+4
[53]
HvDEFL4-167-77                AGHGKRYT-GRG+3
100% germination inhibition of C. neoformans at 300 μM; 25% germination inhibition of C. albicans at 300 μM; 34% germination inhibition of F. culmorum at 300 μM; 32% germination inhibition of F. verticillioides at 300 μM; No activity at 300 μM against C. michiganensis, F. oxysporum, F. solani, P. savastanoi and P. carotovorum.[53]
Table 13. OefDef1.1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
Table 13. OefDef1.1 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red, and substituted amino acids are in green. Gaps (−) were introduced to improve the alignment. The α-core is underlined with a dotted line, and the γ-core is with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
OefDef1.1     KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNRHSKHYGCYCYYRHCY+8
IC50 = 1.6 μM against F. graminearum (MIC = 3 μM); IC50 = 1.1 μM against F. virguliforme (MIC = 3 μM); IC50 = 0.4 μM against F. oxysporum (MIC = 1.5 μM); IC50 = 0.7 μM against B. cinerea (MIC = 1.5 μM).[10]
OefDef1.1_V1     KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGRCRG----FRRRCYCYYRHCY+10
IC50 = 2−3 μM against F. oxysporum; IC50 = 2−3 μM against B. cinerea.[10]
OefDef1.1_V2     KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACHVRN-GKHM-CYCYYRHCY+7
IC50 = 0.3−0.75 μM against F. oxysporum; IC50 = 0.7−1.5 μM against B. cinerea.[10]
OefDef1.1_V3     KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACAAARHSKHYGCYCYYRHCY+7
Displayed antifungal activity similar to that of the wild-type OefDef1.1.[10]
OefDef1.1_V4     KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNAAAKHYGCYCYYRHCY+7
Displayed antifungal activity similar to that of the wild-type OefDef1.1.[10]
OefDef1.1_V5     KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNRHSAAAACYCYYRHCY+7
Was even more potent than the wild-type OefDef1.1.[10]
Table 14. Snakins and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. Gaps (−) were introduced to improve the alignment. The γ-core is underlined with a solid line.
Table 14. Snakins and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. Gaps (−) were introduced to improve the alignment. The γ-core is underlined with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
SlSN2----------------------------------------IQTDQVSSNA---ISEGADSYK-KI
DCGGACAARCRLSSRPR-LCHRACGTCCARCNCVPPGTSGNTETCP-CYASLTTHG--NKRKCP
+6
[46]
γ48-65SlSN2   GACAARCRLSSRPR-LCHR+5
IC50 = 4.2 μM against C. neoformans; IC50 = 23.1 μM against C. michiganensis; IC50 = 42.1 μM against F. culmorum; IC50 = 57.1 μM against F. oxysporum; IC50 = 47.5 μM against F. solani; IC50 = 152.0 μM against F. verticilllioides; 96% growth inhibition of C. albicans at 300 μM; 16% growth inhibition of P. savastanoi at 300 μM; 66% growth inhibition of P. carotovorum at 300 μM; 46% growth inhibition of B. cinerea at 300 μM; 31% growth inhibition of B. sorokiniana at 300 μM.[46]
SlSN9QDSIIDLKEVEEDKQQHVGLSQALRVFTRGANRRLVQDIVLKVAKYLNNGDIALAPAPAPPPSPL
DCGGLCKYRCSLHSRPN-VCFRACGTCCVRCKCVPPGTFGNREKCGKCYTEMTTHG--NKTKCP
+8
[46]
γ89-106SlSN9   GLCKYRCSLHSRPN-VCFR+4
IC50 = 5.1 μM against C. neoformans; IC50 = 24.0 μM against C. michiganensis; IC50 = 42.4 μM against F. culmorum; IC50 = 138.8 μM against F. solani; IC50 = 99.8 μM against F. verticilllioides; 96% growth inhibition of C. albicans at 300 μM; 100% growth inhibition of P. savastanoi at 300 μM; 58% growth inhibition of P. carotovorum at 300 μM; 58% growth inhibition of F. oxysporum at 300 μM; 60% growth inhibition of B. cinerea at 300 μM; 33% growth inhibition of B. sorokiniana at 300 μM.[46]
SlSN10-----------------------------------------LQEVISGKP---PAPSPQPPK-PI
DCTGSCKTRCSKSSRQN-LCNRACGSCCRTCHCVPPGTSGNYEACP-CYFNLTTHN--STRKCP
+7
[46]
γ47-64SlSN10   GSCKTRCSKSSRQN-LCNR+5
IC50 = 126.7 μM against F. culmorum; IC50 = 43.8 μM against F. oxysporum; 96% growth inhibition of C. neoformans at 300 μM; 90% growth inhibition of C. albicans at 300 μM; 94% growth inhibition of C. michiganensis at 300 μM; 18% growth inhibition of P. savastanoi at 300 μM; 65% growth inhibition of P. carotovorum at 300 μM; 39% growth inhibition of B. cinerea at 300 μM; 22% growth inhibition of B. sorokiniana at 300 μM; no activity against F. verticillioides at 300 μM.[46]
TkSN1--------------------------------------------------------------ASG
FCAGKCAVRCARSRAKRGACMKYCGLCCEECACVPTGRSGSRDECP-CYRDMLTAGPRKRPKCP
+9
[53]
TkSN139-57   GKCAVRCARSRAKRGACMK+7
IC50 = 6.0 μM against C. neoformans (100% germination inhibition at 20 μM); 98% germination inhibition of C. albicans at 300 μM; IC50 = 12.0 μM against C. michiganensis (100% germination inhibition at 50 μM); IC50 = 27.5 μM against F. culmorum (80% germination inhibition at 150 μM); IC50 = 93.6 μM against F. oxysporum (68% germination inhibition at 150 μM); 54% germination inhibition of F. solani at 300 μM; 18% germination inhibition of P. savastanoi at 180 μM; 59% germination inhibition of P. carotovorum at 300 μM; no activity against F. verticillioides at 300 μM.[53]
Table 15. nsLTPs and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. Gaps (−) were introduced to improve the alignment. The γ-core is underlined with a solid line.
Table 15. nsLTPs and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. Gaps (−) were introduced to improve the alignment. The γ-core is underlined with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
SlLTPg2.4-----------AQLSSDCTNVL-----VSMSPCLNYITGN-SSSSPSSGCCTQLGTVVKNNPECLCQVLNGGGS--NMGL
NINQTQALALPNACKVQT-PSISKCNAGSPTSSPAGTPSSPNTGGSGSGSIPSSRDASNDASLTKMIDLPFFLILFISSYASAFMA
0
[46]
γ56-72SlLTPg2.4                           SGCCTQLGTVVKNNPEC0
8% growth inhibition of C. albicans at 300 μM; 4% growth inhibition of C. michiganensis at 300 μM; 2% growth inhibition of P. savastanoi at 300 μM; 4% growth inhibition of P. carotovorum at 300 μM; no activity against C. neoformans, F. culmorum, F. oxysporum, F. solani, F. verticillioides, B. cinerea and B. sorokiniana at 300 μM.[46]
SlLTPg2.5------------QESDDCTNVW-----VSMSPCLNYYVD--STSPQFSGCCTQLSTVVDEKSECLCQVLK------DLG
LNINQTRLSALTTACKVQT-PPASNCNGRGSASQGGPNDATSTNMAAPFSFFFLLIASYASIINIT
−4
[46]
γ53-69SlLTPg2.5                           SGCCTQLSTVVDEKSEC−2
19% growth inhibition of C. neoformans at 300 μM; 13% growth inhibition of C. albicans at 300 μM; 8% growth inhibition of C. michiganensis at 300 μM; 20% growth inhibition of P. savastanoi at 300 μM; 5% growth inhibition of P. carotovorum at 300 μM; no activity against F. culmorum, F. oxysporum, F. solani, F. verticillioides, B. cinerea and B. sorokiniana at 300 μM.[46]
SlLTPg2.8QDSPPAPEAPAPSPGVDCFRVL-----VNMSDCLAFVERGSNTTTPGKGCCPEIAGLLDSNPICLCHMLGRAHSGAKIG
FNIDVDKALKLPSACSLEF-PPSTTCSDLGIPVGAPLPSEESPAPSPGKQTLAVFSVLF
−5
[46]
γ70-86SlLTPg2.8                           KGCCPEIAGLLDSNPIC−1
54% growth inhibition of C. neoformans at 300 μM; 2% growth inhibition of C. albicans at 300 μM; 15% growth inhibition of P. savastanoi at 300 μM; 5% growth inhibition of P. carotovorum at 300 μM; 22% growth inhibition of B. sorokiniana at 300 μM; no activity against C. michiganensis, F. culmorum, F. oxysporum, F. solani, F. verticillioides, B. cinerea at 300 μM.[46]
TkLTP2.25--------------AAGCDASA-------LSPCVGAIMVG---GAVTPGCCARLRAQRA----CLCQYAREP----SYR
GYVNSPRAQSVVAACGLPR----PKC
+6
[53]
TkLTP2.2550-62                            PGCCARLRAQRA----C+3
IC50 = 45.0 μM against C. neoformans (100% germination inhibition at 100 μM); 13% germination inhibition of C. albicans at 300 μM; IC50 = 94.6 μM against C. michiganensis (95% germination inhibition at 300 μM); 36% germination inhibition of F. culmorum at 300 μM; 34% germination inhibition of F. oxysporum at 300 μM; 25% germination inhibition of P. savastanoi at 300 μM; 8% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. solani and F. verticillioides.[53]
TkLTPd5.6--------------AGECGKTPADKMALKLAPCASAGQDP--KSAPSSGCCTAVHTIGKQSPKCLCAVMLSDT---AKS
AGIKPEVAMSIPKRCNLVDRPVGYKCGAYTLP
+6
[53]
TkLTPd5.659-75                           SGCCTAVHTIGKQSPKC+2
11% germination inhibition of C. neoformans at 300 μM; 24% germination inhibition of C. albicans at 300 μM; 23% germination inhibition of C. michiganensis at 300 μM; 18% germination inhibition of P. savastanoi at 300 μM; 2% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against F. culmorum, F. oxysporum, F. solani, F. verticillioides.[53]
Table 16. SlMEG2, thionin TkThi1, knottin Tk-AMP-K2, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. The γ-core is underlined with a solid line.
Table 16. SlMEG2, thionin TkThi1, knottin Tk-AMP-K2, and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. The γ-core is underlined with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
SlMEG2APISQAKGSEMVPLIEPGKAEKMMIMLNNTRRKLGSFQICALCTCCGG
KAVCLPTPCCYAINCNIPNRPFGYCSFTPKTCNCFGCHY
+6
[46]
γ92-104SlMEG2            RPFGYCSFTPKTC+2
97% growth inhibition of C. neoformans at 300 μM; 92% growth inhibition of C. michiganensis at 300 μM; 16% growth inhibition of P. savastanoi at 300 μM; 40% growth inhibition of B. cinerea at 300 μM; 36% growth inhibition of B. sorokiniana at 300 μM; no activity against C. albicans, P. carotovorum, F. culmorum, F. oxysporum, F. solani, F. verticillioides at 300 μM.[46]
TkThi1GWCDRACLFQCTHSGGQEDRCRTFCRCPNKSGERNALELCTSGCSSSIC
GIINTVDGTEAGKHAAVGRCNEACASFCSKGEHGIQSVAT
0
[53]
TkThi196-109           VGRCNEACASFCSK+1
13% germination inhibition of C. albicans at 300 μM; 40% germination inhibition of C. michiganensis at 300 μM; 7% germination inhibition of P. carotovorum at 300 μM; no activity at 300 μM against C. neoformans, F. culmorum, F. oxysporum, F. solani, F. verticillioides and P. savastanoi.[53]
Tk-AMP-K2PGCPVGQLMKCRTTFPCCGGRCVYC+3
[53]
Tk-AMP-K210-23      KCRTTFPCCGGRCV+3
100% germination inhibition of C. neoformans at 300 μM; 49% germination inhibition of C. albicans at 300 μM; 71% germination inhibition of C. michiganensis at 150 μM; 42% germination inhibition of F. culmorum at 300 μM; 11% germination inhibition of F. oxysporum at 300 μM; 34% germination inhibition of F. solani at 150 μM; 34% germination inhibition of F. verticillioides at 300 μM; 85% germination inhibition of P. savastanoi at 300 μM; 70% germination inhibition of P. carotovorum at 300 μM.[53]
Table 17. WAMP-2 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. The γ-core is underlined with a solid line.
Table 17. WAMP-2 and derived peptides: sequence, net charge at pH 7.0, and antimicrobial activity. Cysteine residues are shown in red. The γ-core is underlined with a solid line.
PeptideAmino Acid SequenceNet Charge at pH 7.0
Antimicrobial ActivityReference
WAMP-2AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGKGSCQSQCRGCR+5
IC50 = 6.6 μM against B. sorokiniana; IC50 = 23.0 μM against A. alternata; IC50 = 8.0 μM against Cladosporium cucumerinum; IC50 = 8.8 μM against F. oxysporum; IC50 = 52.9 μM against F. culmorum.[54]
WAMP-NAQRCGDQARGAKC+2
IC50 = 53.5 μM against B. sorokiniana (80.8% inhibition at 200 μg/mL); IC50 = 75.3 μM against A. alternata (77.2% inhibition at 200 μg/mL); IC50 = 205.5 μM against C. cucumerinum (43.6% inhibition at 200 μg/mL); IC50 = 174.6 μM against F. oxysporum (44.9% inhibition at 200 μg/mL); IC50 = 243.8 μM against F. culmorum (45.0% inhibition at 200 μg/mL); IC50 > 500 μM against F. avenaceum (40.4% inhibition at 400 μg/mL); IC50 = 161.5 μM against Parastagonospora nodorum (63.5% inhibition at 400 μg/mL).[54]
WAMP-G1          LCCGKYGFCGSG+1
IC50 = 228.7 μM against B. sorokiniana (45.7% inhibition at 200 μg/mL); IC50 > 500 μM against A. alternata (16.7% inhibition at 200 μg/mL); IC50 > 500 μM against C. cucumerinum (19.2% inhibition at 400 μg/mL); IC50 > 500 μM against F. oxysporum (16.7% inhibition at 400 μg/mL); IC50 > 500 μM against F. culmorum (6.5% inhibition at 400 μg/mL); IC50 > 500 μM against P. nodorum (28.5% inhibition at 400 μg/mL); no activity against F. avenaceum at 400 μg/mL[54]
WAMP-G2           CCGKYGFCGSGDAYC0
IC50 = 127.3 μM against B. sorokiniana (54.3% inhibition at 200 μg/mL); IC50 = 94.9 μM against A. alternata (61.1% inhibition at 200 μg/mL); IC50 = 267.4 μM against C. cucumerinum (23.6% inhibition at 200 μg/mL); IC50 = 255.1 μM against F. oxysporum (35.5% inhibition at 200 μg/mL); IC50 > 500 μM against F. culmorum (26.2% inhibition at 400 μg/mL); IC50 = 393.1 μM against F. avenaceum (17.5% inhibition at 200 μg/mL); IC50 = 276.5 μM against P. nodorum (24.1% inhibition at 200 μg/mL).[54]
WAMP-C                   GKGSCQSQCRGCR+3
IC50 = 313.6 μM against B. sorokiniana (48.7% inhibition at 400 μg/mL); IC50 = 401.9 μM against A. alternata (45.1% inhibition at 400 μg/mL); IC50 = 3.9 μM against C. cucumerinum (70.2% inhibition at 50 μg/mL); IC50 > 500 μM against F. oxysporum (11.5% inhibition at 400 μg/mL); IC50 > 500 μM against F. culmorum (23% inhibition at 400 μg/mL); IC50 = 240.7 μM against P. nodorum (59.9% inhibition at 400 μg/mL); no activity against F. avenaceum at 400 μg/mL.[54]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Slezina, M.P.; Istomina, E.A.; Korostyleva, T.V.; Odintsova, T.I. The γ-Core Motif Peptides of Plant AMPs as Novel Antimicrobials for Medicine and Agriculture. Int. J. Mol. Sci. 2023, 24, 483. https://doi.org/10.3390/ijms24010483

AMA Style

Slezina MP, Istomina EA, Korostyleva TV, Odintsova TI. The γ-Core Motif Peptides of Plant AMPs as Novel Antimicrobials for Medicine and Agriculture. International Journal of Molecular Sciences. 2023; 24(1):483. https://doi.org/10.3390/ijms24010483

Chicago/Turabian Style

Slezina, Marina P., Ekaterina A. Istomina, Tatyana V. Korostyleva, and Tatyana I. Odintsova. 2023. "The γ-Core Motif Peptides of Plant AMPs as Novel Antimicrobials for Medicine and Agriculture" International Journal of Molecular Sciences 24, no. 1: 483. https://doi.org/10.3390/ijms24010483

APA Style

Slezina, M. P., Istomina, E. A., Korostyleva, T. V., & Odintsova, T. I. (2023). The γ-Core Motif Peptides of Plant AMPs as Novel Antimicrobials for Medicine and Agriculture. International Journal of Molecular Sciences, 24(1), 483. https://doi.org/10.3390/ijms24010483

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop